<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Betamimetics for inhibiting preterm labour - Neilson, JP - 2014 | Cochrane Library</title> <meta content="Betamimetics for inhibiting preterm labour - Neilson, JP - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004352.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Betamimetics for inhibiting preterm labour - Neilson, JP - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004352.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004352.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Betamimetics for inhibiting preterm labour" name="citation_title"/> <meta content="James P Neilson" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="jneilson@liverpool.ac.uk" name="citation_author_email"/> <meta content="Helen M West" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Therese Dowswell" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD004352.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/02/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004352.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004352.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004352.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenergic beta‐Agonists [*therapeutic use]; Fenoterol [therapeutic use]; Hexoprenaline [therapeutic use]; Obstetric Labor, Premature [*prevention &amp; control]; Premature Birth [prevention &amp; control]; Randomized Controlled Trials as Topic; Ritodrine [therapeutic use]; Terbutaline [therapeutic use]; Tocolytic Agents [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004352.pub3&amp;doi=10.1002/14651858.CD004352.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="xNbeAU8n";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004352\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004352\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004352.pub3",title:"Betamimetics for inhibiting preterm labour",firstPublishedDate:"Feb 5, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004352.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004352.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004352.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004352.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004352.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004352.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004352.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004352.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004352.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004352.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6789 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004352.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-sec-0098"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-sec-0023"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-sec-0024"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-sec-0095"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/appendices#CD004352-sec-0103"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/table_n/CD004352StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/table_n/CD004352StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Betamimetics for inhibiting preterm labour</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information#CD004352-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>James P Neilson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information#CD004352-cr-0003">Helen M West</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information#CD004352-cr-0004">Therese Dowswell</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information/en#CD004352-sec-0111">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 February 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004352.pub3">https://doi.org/10.1002/14651858.CD004352.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004352-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004352-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004352-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004352-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004352-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004352-abs-0001" lang="en"> <section id="CD004352-sec-0001"> <h3 class="title" id="CD004352-sec-0001">Background</h3> <p>Preterm birth is a major contributor to perinatal mortality and morbidity worldwide. Tocolytic agents are drugs used to inhibit uterine contractions. Betamimetics are tocolytic agents that have been widely used, especially in resource‐poor countries. </p> </section> <section id="CD004352-sec-0002"> <h3 class="title" id="CD004352-sec-0002">Objectives</h3> <p>To assess the effects of betamimetics given to women with preterm labour.</p> </section> <section id="CD004352-sec-0003"> <h3 class="title" id="CD004352-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 December 2013) and reference lists of retrieved studies. </p> </section> <section id="CD004352-sec-0004"> <h3 class="title" id="CD004352-sec-0004">Selection criteria</h3> <p>Randomised controlled trials of betamimetics, administered by any route or any dose, in the treatment of women in preterm labour where betamimetics were compared with other betamimetics, placebo or no treatment. </p> </section> <section id="CD004352-sec-0005"> <h3 class="title" id="CD004352-sec-0005">Data collection and analysis</h3> <p>Two review authors assessed risk of bias and extracted the data independently.</p> </section> <section id="CD004352-sec-0006"> <h3 class="title" id="CD004352-sec-0006">Main results</h3> <p>Twenty‐eight trials were assessed as eligible for inclusion in the review, but eight did not report any outcome data relevant to the review. Results are based on the 20 trials that contributed data. </p> <p>Twelve trials, involving 1367 women, compared betamimetics with placebo. Betamimetics decreased the number of women in preterm labour giving birth within 48 hours (average risk ratio (RR) 0.68, 95% confidence interval (CI) 0.53 to 0.88, 10 trials, 1209 women). There was a decrease in the number of births within seven days (average RR 0.80; 95% CI 0.65 to 0.98, five trials, 911 women) but there was no evidence of a reduction in preterm birth (before 37 weeks' gestation) (RR 0.95; 95% CI 0.88 to 1.03, 10 trials, 1212 women). No benefit was demonstrated for betamimetics for perinatal death (RR 0.84; 95% CI 0.46 to 1.55, 11 trials, 1332 infants), or neonatal death (RR 0.90; 95% CI 0.27 to 3.00, six trials, 1174 infants). No significant effect was demonstrated for respiratory distress syndrome (RR 0.87; 95% CI 0.71 to 1.08, eight trials, 1239 infants). A few trials reported on cerebral palsy, infant death and necrotising enterocolitis; no significant differences between groups were identified for any of these outcomes. Betamimetics were significantly associated with the following outcomes: withdrawal from treatment due to adverse effects; maternal chest pain; dyspnoea; palpitation; tremor; headaches; hypokalaemia; hyperglycaemia; nausea or vomiting; nasal stuffiness; and fetal tachycardia. </p> <p>Nine trials compared different types of betamimetics. Other betamimetics were compared with ritodrine in five trials (n = 948). Other comparisons were examined in single trials: hexoprenaline compared with salbutamol (n = 140), slow versus moderate release salbutamol (n = 52) and salbutamol compared with terbutaline (n = 200). Trials were small, varied, and of insufficient quality to delineate any consistent patterns of effect. </p> </section> <section id="CD004352-sec-0007"> <h3 class="title" id="CD004352-sec-0007">Authors' conclusions</h3> <p>Betamimetics help to delay birth, which may give time to allow women to be transferred to tertiary care or to complete a course of antenatal corticosteroids. However, multiple adverse effects must be considered. The data are too few to support the use of any particular betamimetic. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004352-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004352-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004352-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004352-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004352-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004352-abs-0006">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004352-abs-0004" lang="en"> <h3>Betamimetics for inhibiting preterm labour</h3> <p>Preterm labour is when women go into labour before 37 weeks' gestation<b>.</b> Babies born before term (preterm birth) have poorer outcomes compared with babies who are born at term. The earlier the baby is born, the poorer the outcome. Most preterm births occur in low‐income countries where medical help is less readily available. Preterm birth is a major cause of infant deaths and serious illness worldwide. Preterm birth can result in respiratory distress syndrome and chronic lung disease, bleeding into the fluid spaces (ventricles) within the brain (intraventricular haemorrhage)), generalised infection or infection of the blood stream (sepsis), cerebral palsy and other neuro‐developmental impairments. Even short delays in preterm birth can enable women to reach specialist care and receive 'corticosteroid' drugs that are given to women before birth to improve their babies' lung function. </p> <p>We assessed the benefits of betamimetics (drugs that inhibit contractions of the uterus) given to women with preterm labour against any adverse effects in randomised controlled trials. The betamimetics were administered, by any route or any dose, and compared with placebo, no treatment or other betamimetics. Twenty trials, testing the effect of betamimetics for inhibiting preterm labour, contributed data.The trials were published over a 44‐year period between 1966 and 2010 and were conducted in tertiary care or university hospitals in high‐income countries. </p> <p>A total of 1367 women in preterm labour participated in the 12 trials that compared a betamimetic with placebo or no treatment. Betamimetics decreased the number of women giving birth within 48 hours and there was a decrease in the number of births within seven days. </p> <p>The delay in the timing of birth did not translate into any improvements in neonatal outcomes but most women in the trials were 32 weeks' gestation or more. Betamimetics were not shown to reduce perinatal deaths or respiratory distress syndrome. </p> <p>The side effects for the woman were considerable. These led to cessation of treatment and symptoms such as palpitations, chest pain, headache, difficulty breathing, nausea and/or vomiting. </p> <p>There was not enough evidence from the included trials to suggest that one betamimetic agent was superior to another. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004352-sec-0098" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004352-sec-0098"></div> <h3 class="title" id="CD004352-sec-0099">Implications for practice</h3> <section id="CD004352-sec-0099"> <p>Betamimetics are widely used especially in resource‐poor countries, and take effect rapidly. Betamimetics are effective in delaying birth for 48 hours, sufficient time to allow the transfer of a woman to a higher level of care and to allow completion of an antenatal corticosteroid to facilitate fetal lung maturation. However, this benefit is balanced by more frequent unpleasant and sometimes potentially serious adverse effects which significantly increase the likelihood of having to discontinue betamimetic treatment. </p> </section> <h3 class="title" id="CD004352-sec-0100">Implications for research</h3> <section id="CD004352-sec-0100"> <p>Any future studies should aim to improve diagnostic criteria for preterm labour and have sufficient power to detect clinically meaningful differences in important neonatal outcomes. However, given the less favourable adverse effect profile of betamimetics in comparison to other tocolytic drugs, it seems unlikely that further trials involving betamimetics will be conducted. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004352-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004352-sec-0022"></div> <p>Preterm birth is defined as birth occurring before 37 completed weeks of pregnancy (<a href="./references#CD004352-bbs2-0119" title="Anonymous . WHO recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Acta Obstetricia et Gynecologica Scandinavica1977;56:247‐53. ">WHO 1977</a>). Of the four million estimated neonatal deaths in the world each year, 99% occur in low‐income countries and around one‐third are directly attributable to premature (preterm) birth (<a href="./references#CD004352-bbs2-0109" title="LawnJE , CousensS , ZupanJ . 4 million neonatal deaths: When? Where? Why?. Lancet2005;365:5‐11. ">Lawn 2005</a>). Preterm birth is thus the leading cause of neonatal death (<a href="./references#CD004352-bbs2-0110" title="LiuL , JohnsonHL , CousensS , PerinJ , ScottS , LawnJE , et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet2012;379(9832):2151‐61. ">Liu 2012</a>). There is considerable regional variation in the incidence of preterm birth; 6.2% in Europe, 10.6% in the US and higher rates in Africa (<a href="./references#CD004352-bbs2-0095" title="BeckS , WojdylaD , SayL , BetranAP , MerialdiM , RequejoJH , et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization2010;88(1):31‐8. ">Beck 2010</a>; <a href="./references#CD004352-bbs2-0096" title="BlencoweH , CousensS , OestergaardMZ , ChouD , MollerAB , NarwalR , et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet2012;379(9832):2162‐72. ">Blencowe 2012</a>). Accurate assessment of gestational age is challenging in low‐income countries but accurate ultrasound‐based assessments in Malawi found an incidence as high as 17% (<a href="./references#CD004352-bbs2-0118" title="van denBroekNR , WhiteSA , GoodallM , NtonyaC , KayiraE , et al. The APPLe study: a randomized, community‐based, placebo‐controlled trial of azithromycin for the prevention of preterm birth, with meta‐analysis. PLoS Medicine2009;6:e10000191. ">van den Broek 2009</a>). Preterm birth is also a leading cause of perinatal morbidity and of morbidities that persist into childhood. Preterm birth can cause respiratory distress syndrome, bronchopulmonary dysplasia (a chronic lung disease, which can follow respiratory distress syndrome), intraventricular haemorrhage (bleeding into the fluid spaces (ventricles) within the brain), sepsis (generalised infection or infection of the blood stream), cerebral palsy and other forms of neuro‐developmental impairment (<a href="./references#CD004352-bbs2-0102" title="GladstoneM , NeilsonJP , WhiteS , KafulafulaG , van denBroekN . Post‐neonatal mortality, morbidity, and developmental outcome after ultrasound‐dated preterm birth in rural Malawi: a community‐based cohort study. PLoS Medicine2011;8:e1001121. ">Gladstone 2011</a>), blindness and deafness. Preterm infants born in high‐income settings often require intensive care, which is costly (<a href="./references#CD004352-bbs2-0114" title="PetrouS , SachT , DavidsonL . The long‐term costs of preterm birth and low birth weight: results of systematic review. Child Care, Health and Development2001;27:97‐115. ">Petrou 2001</a>) and stressful. Intensive care is largely unavailable in those parts of the world with the greatest burden of preterm births, namely Africa and South Asia.<br/> <br/> The mechanisms or pathogenesis of preterm labour are not well understood. The causes of spontaneous preterm labour may involve genetic factors, stress, inflammatory response, infection, mechanical factors and haemorrhage (<a href="./references#CD004352-bbs2-0103" title="GoldenbergRL , CulhaneJF , IamsJD , RomeroR . Epidemiology and causes of preterm birth. Lancet2008;371:75‐84. ">Goldenberg 2008</a>). Antenatal strategies to try to prevent preterm birth have been largely disappointing, and the rate of preterm birth has not decreased (<a href="./references#CD004352-bbs2-0097" title="ChangHH , LarsonJ , BlencoweH , SpongCY , HowsonCP , Cairns‐SmithS , et al. Preventing preterm births; analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet2013;381(9862):223‐34. ">Chang 2013</a>). </p> <p>Tocolytic drugs (drugs that inhibit contractions of the uterus) have been used to try to prolong pregnancy when preterm labour is diagnosed. Theoretically, tocolysis could improve perinatal outcomes by (a) allowing the fetus to mature further in utero before being born, (b) enhancing lung maturation in the fetus by giving corticosteroid treatment to the mother (<a href="./references#CD004352-bbs2-0116" title="RobertsD , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2] ">Roberts 2006</a>), and (c) allowing time for in‐utero transfer to a tertiary care centre with better facilities for care of the premature newborn, including neonatal intensive care facilities. </p> <p>Betamimetics (isoxsuprine, hexoprenaline, orciprenaline, ritodrine, terbutaline, and salbutamol) have been used extensively in the past. Beta‐adrenergic agonists activate adenyl cyclase to form cyclic adenosine 3',5' monophosphate (cAMP). The increased cellular levels of cAMP decrease myosin light‐chain kinase activity, both by phosphorylation of the myosin light‐chain kinase itself, and by reducing intracellular calcium through increasing calcium uptake by sarcoplasmic reticulum (<a href="./references#CD004352-bbs2-0101" title="GaborH , JamesMR . Biochemistry and pharmacology of the myometrium and labor: regulation at the cellular and molecular levels. American Journal of Obstetrics and Gynecology1982;142:225‐37. ">Gabor 1982</a>). </p> <p>The ideal tocolytic agent is one which is effective in prolonging pregnancy but has no side effects for the woman or the baby. Betamimetics stimulate beta‐adrenergic receptors and may cause palpitations, tremor, nausea, vomiting, headaches, nervousness, anxiety, chest pain, shortness of breath, and a range of biochemical disturbances such as hyperglycaemia (high blood sugar level) and hypokalaemia (low serum potassium level). Moreover, pulmonary oedema (fluid accumulation in the lungs) may occur (<a href="./references#CD004352-bbs2-0111" title="MabieWC , PernollML , WittyJB , BiswasMK . Pulmonary edema induced by betamimetic drugs. Southern Medical Journal1983;76:1354‐60. ">Mabie 1983</a>) and has even been associated with maternal death. The occurrence of side effects may necessitate some women stopping the medication. Betamimetics cross the placenta and may cause fetal tachycardia (increase fetal heart rate), and hypoglycaemia (low blood sugar level) and hyperinsulinism after birth. When considering whether or not to use tocolytic agents in preterm labour, consideration needs to be given to the risks and benefits for both mother and infant, including the side effects of any medication used. </p> <p>Although the use of betamimetics to inhibit preterm labour has lost popularity in high‐income settings because of safety concerns, they are still used elsewhere, especially in resource‐poor countries. We aim to review the evidence for benefits and harms of betamimetics in this review. The use of betamimetics to try to reduce the risk of preterm birth in twin pregnancies (<a href="./references#CD004352-bbs2-0120" title="YamasmitW , ChaithongwongwatthanaS , TolosaJE , LimpongsanurakS , PereiraL , LumbiganonP . Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD004733.pub3] ">Yamasmit 2012</a>) and as maintenance therapy after acute treatment of preterm labour (<a href="./references#CD004352-bbs2-0099" title="DoddJM , CrowtherCA , MiddletonP . Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD003927.pub3] ">Dodd 2012</a>) are addressed in other Cochrane reviews. </p> <p>In addition to betamimetics, several alternative tocolytic agents (that use different physiological mechanisms to inhibit labour) have been examined in trials and used in clinical practice. These include calcium channel blockers, cyclo‐oxygenase (COX) inhibitors (prostaglandin inhibitors), magnesium sulphate, nitric oxide donors, progestational agents, relaxin and oxytocin receptor antagonists. The effectiveness and side effects of these agents have been examined in other Cochrane reviews (<a href="./references#CD004352-bbs2-0094" title="BainE , HeatleyE , HsuK , CrowtherCA . Relaxin for preventing preterm birth. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD010073.pub2] ">Bain 2013</a>; <a href="./references#CD004352-bbs2-0098" title="CrowtherCA , HillerJE , DoyleLW . Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001060] ">Crowther 2002</a>; <a href="./references#CD004352-bbs2-0100" title="DuckittK , ThorntonS . Nitric oxide donors for the treatment of preterm labour. Cochrane Database of Systematic Reviews2002, Issue 3. [DOI: 10.1002/14651858.CD002860] ">Duckitt 2002</a>; <a href="./references#CD004352-bbs2-0107" title="KingJF , FlenadyV , PapatsonisD , DekkerG , CarbonneB . Calcium channel blockers for inhibiting preterm labour. Cochrane Database of Systematic Reviews2003, Issue 1. [DOI: 10.1002/14651858.CD002255] ">King 2003</a>; <a href="./references#CD004352-bbs2-0108" title="KingJF , FlenadyV , ColeS , ThorntonS . Cyclo‐oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD001992.pub2] ">King 2005</a>; <a href="./references#CD004352-bbs2-0112" title="NardinJM , CarroliG , AlfirevicZ . Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006169] ">Nardin 2006</a>; <a href="./references#CD004352-bbs2-0113" title="PapatsonisD , FlenadyV , ColeS , LileyH . Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD004452.pub2] ">Papatsonis 2005</a>; <a href="./references#CD004352-bbs2-0117" title="SuLL , SamuelM , ChongYS . Progestational agents for treating threatened or established preterm labour. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD006770.pub2] ">Su 2010</a>), and their relative effects have been explored in a recent network meta‐analysis (<a href="./references#CD004352-bbs2-0104" title="HaasDM , CaldwellDM , KirkpatrickP , McIntoshJJ , WeltonNJ . Tocolytic therapy for preterm delivery: systematic review and network meta‐analysis. BMJ2012;345:e6226. ">Haas 2012</a>). </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004352-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004352-sec-0023"></div> <p>To assess the effects of betamimetics in the treatment of preterm labour.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004352-sec-0024" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004352-sec-0024"></div> <section id="CD004352-sec-0025"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004352-sec-0026"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (including cluster‐randomised trials) comparing outcomes for women and infants in which betamimetics were used, by any route or any dose, to inhibit preterm labour with outcomes in controls with betamimetics, placebo or no treatment. We did not include trials where the method of allocation to groups was not truly random (e.g. allocation by day of the week). </p> </section> <section id="CD004352-sec-0027"> <h4 class="title">Types of participants</h4> <p>Pregnant women assessed as being in spontaneous preterm labour and considered suitable for tocolytic agents. </p> <p>For the purpose of the review, preterm labour was defined by trial authors (with intact or ruptured membranes) unless they contradicted the gestational age criterion. </p> </section> <section id="CD004352-sec-0028"> <h4 class="title">Types of interventions</h4> <p>Betamimetics, administered by any route or any dose, in the treatment of women in preterm labour where betamimetics were compared with other betamimetics, placebo or no treatment. </p> </section> <section id="CD004352-sec-0029"> <h4 class="title">Types of outcome measures</h4> <section id="CD004352-sec-0030"> <h5 class="title">Primary outcomes</h5> <p>Primary outcomes were chosen as being most representative of the clinically important measures of effectiveness. </p> <p> <ol id="CD004352-list-0001"> <li> <p>Birth within 48 hours of treatment.</p> </li> <li> <p>Perinatal death (at seven days).</p> </li> <li> <p>Respiratory distress syndrome.</p> </li> <li> <p>Chronic lung disease or bronchopulmonary dysplasia as defined by oxygen dependency at 28 days or 36 weeks postmenstrual age, or both. </p> </li> <li> <p>Severe neuroradiological abnormality, for example, cystic periventricular leukomalacia (softening of the brain near the ventricles because brain tissue in this area has died) or grade III to IV periventricular haemorrhage, or both. </p> </li> <li> <p>Abnormal long‐term neurodevelopmental status at more than 12 months corrected age (defined as moderate to severe developmental delay and/or cerebral palsy, and/or sensory impairment, for example, blind and deaf). </p> </li> <li> <p> Neonatal length of hospital stay.</p> </li> </ol> </p> </section> <section id="CD004352-sec-0031"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004352-list-0002"> <li> <p>Time to birth (interval between randomisation and the birth):</p> <ol id="CD004352-list-0003"> <li> <p>birth within seven days;</p> </li> <li> <p>birth before 28 completed weeks;</p> </li> <li> <p>birth before 34 completed weeks;</p> </li> <li> <p>birth before 37 completed weeks.</p> </li> </ol> </li> <li> <p>Adverse events:</p> <ol id="CD004352-list-0004"> <li> <p>cessation of treatment due to adverse drug reaction;</p> </li> <li> <p>serious maternal outcomes, for example, maternal death, cardiac arrest, respiratory arrest, admission to intensive care unit; </p> </li> <li> <p>maternal adverse drug reactions (all), for example, palpitation, tachycardia, cardiac arrhythmias, pulmonary oedema, myocardial ischaemia, chest pain, dyspnoea, tremor, hypotension, hyperglycaemia, hypokalaemia, nausea, vomiting, nasal stuffiness, headaches, nervousness, anxiety; </p> </li> <li> <p>fetal and neonatal side effects (all), for example, hypoglycaemia, fetal tachycardia.</p> </li> </ol> </li> <li> <p>Neonatal morbidity:</p> <ol id="CD004352-list-0005"> <li> <p>neonatal sepsis;</p> </li> <li> <p>necrotising enterocolitis (an inflammation causing injury to the bowel);</p> </li> <li> <p>retinopathy of prematurity (abnormal growth of blood vessels in the baby's eye).</p> </li> </ol> </li> <li> <p>Neonatal death (at 28 days).</p> </li> <li> <p>Infant death (at 12 months of age).</p> </li> </ol> </p> </section> </section> </section> <section id="CD004352-sec-0032"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004352-sec-0033"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register by contacting the Trials Search Co‐ordinator (31 December 2013). </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD004352-list-0006"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE;</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. </p> </section> <section id="CD004352-sec-0034"> <h4 class="title">Searching other resources</h4> <p>We scanned the reference lists of all articles found.</p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD004352-sec-0035"> <h3 class="title" id="CD004352-sec-0035">Data collection and analysis</h3> <p>For the methods used when assessing the trials identified in the previous version of this review, <i>see</i><a href="./appendices#CD004352-sec-0104">Appendix 1</a>. </p> <p>For this update, we used the following methods when assessing the reports identified by the updated searches. </p> <section id="CD004352-sec-0036"> <h4 class="title">Selection of studies</h4> <p>Two review authors (T Dowswell (TD) and H West (HW)) independently assessed eligibility for inclusion for studies identified by the search strategy. We resolved any disagreement through discussion or, if required, we consulted the third author (J Neilson (JPN)). </p> </section> <section id="CD004352-sec-0037"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors (TD and HW) extracted data independently using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author (JPN) We entered data into Review Manager software (<a href="./references#CD004352-bbs2-0115" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD004352-sec-0038"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004352-bbs2-0105" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved any disagreement by discussion or by involving a third assessor. </p> <section id="CD004352-sec-0039"> <h5 class="title">(1) Sequence generation (checking for possible selection bias)</h5> <p>We have described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD004352-list-0007"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear.</p> </li> </ul> </p> </section> <section id="CD004352-sec-0040"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We have described for each included study the method used to conceal the allocation sequence and determined whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD004352-list-0008"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear.   </p> </li> </ul> </p> </section> <section id="CD004352-sec-0041"> <h5 class="title">(3) Blinding (checking for possible performance and detection bias)</h5> <p>We have described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding could not have affected the results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD004352-list-0009"> <li> <p>high, low or unclear risk of bias for participants;</p> </li> <li> <p>high, low or unclear risk of bias for personnel;</p> </li> <li> <p>high, low or unclear risk of bias for outcome assessors.</p> </li> </ul> </p> </section> <section id="CD004352-sec-0042"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations) </h5> <p>We have described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We have stated whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.  Where sufficient information was reported, or supplied by the trial authors, we re‐included missing data in the analyses. We assessed methods as: </p> <p> <ul id="CD004352-list-0010"> <li> <p>low risk of bias;</p> </li> <li> <p>high risk of bias;</p> </li> <li> <p>unclear.</p> </li> </ul> </p> <p>Studies where more than 20% of the participants were lost to follow‐up have been excluded. We also excluded outcomes where there was more than 20% missing data. We considered that serious sample attrition meant that studies were at high risk of bias and results would be difficult to interpret. </p> </section> <section id="CD004352-sec-0043"> <h5 class="title">(5) Selective reporting bias</h5> <p>We have described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD004352-list-0011"> <li> <p>low risk of bias (where it was clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear.</p> </li> </ul> </p> </section> <section id="CD004352-sec-0044"> <h5 class="title">(6) Other sources of bias</h5> <p>We have described for each included study any important concerns we had about other possible sources of bias, such as baseline imbalance. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD004352-list-0012"> <li> <p>high risk of other bias;</p> </li> <li> <p>low risk of other bias;</p> </li> <li> <p>unclear.</p> </li> </ul> </p> </section> <section id="CD004352-sec-0045"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD004352-bbs2-0105" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD004352-sec-0058">Sensitivity analysis</a>. </p> </section> </section> <section id="CD004352-sec-0046"> <h4 class="title">Measures of treatment effect</h4> <section id="CD004352-sec-0047"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we have presented results as summary risk ratio with 95% confidence intervals.<i> </i> </p> </section> <section id="CD004352-sec-0048"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference if outcomes were measured in the same way between trials. Where appropriate, we planned to use the standardised mean difference to combine trials that measured the same outcome, but used different methods. <b> </b> </p> </section> </section> <section id="CD004352-sec-0049"> <h4 class="title">Unit of analysis issues</h4> <section id="CD004352-sec-0050"> <h5 class="title">Cluster‐randomised trials</h5> <p>None of the trials in this version of the review randomised clusters. In future updates if such trials are identified we will include them in the analyses along with individually‐randomised trials. We will adjust their sample sizes using the methods described in the <i>Handbook</i> (<a href="./references#CD004352-bbs2-0105" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) using an estimate of the intra‐cluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform subgroup analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD004352-sec-0051"> <h5 class="title">Cross‐over trials </h5> <p>We have not included cross‐over trials; this type of study design was not considered suitable for this type of intervention. </p> </section> <section id="CD004352-sec-0052"> <h5 class="title">Other unit of analysis issues</h5> <p>Where appropriate, in multi‐arm trials with more than one arm examining the same betamimetic (e.g. different doses), we combined results for the betamimetics group to form a single pair‐wise comparison. </p> <p>If we had identified any multi‐arm studies where two different betamimetics were compared with a control group (placebo or no treatment), we planned to divide the control group between the two experimental arms (dividing control event rate and sample size by two for dichotomous outcomes, and dividing the sample size by two and assuming the same mean and standard deviation for continuous outcomes). No such trials were identified for inclusion in this version of the review. </p> </section> </section> <section id="CD004352-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD004352-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau<sup>2</sup>, I<sup>2</sup> and Chi<sup>2</sup> statistics. We regarded heterogeneity as substantial if a Tau<sup>2</sup> was greater than zero and either an I<sup>2</sup> was greater than 30% or there was a low P value (less than 0.10) in the Chi<sup>2</sup> test for heterogeneity. </p> </section> <section id="CD004352-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>Where there were 10 or more studies in the meta‐analysis, we investigated reporting biases (such as publication bias) using funnel plots. We assessed funnel plot asymmetry visually, and if there was any obvious asymmetry identified we planned to use formal tests for funnel plot asymmetry (<a href="./references#CD004352-bbs2-0105" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD004352-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD004352-bbs2-0115" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials examined the same intervention, and the trials’ populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average range of possible treatment effects and we have discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not considered clinically meaningful, we did not combine trials. </p> <p>For random‐effects analyses, the results are presented as the average treatment effect with its 95% confidence interval, and the estimates of  Tau<sup>2</sup> and I<sup>2</sup>. </p> </section> <section id="CD004352-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out subgroup analysis of trials where antenatal corticosteroids were given routinely to see if this had any impact on the treatment effect. </p> <p>Studies that explicitly stated that both the intervention and control participants received corticosteroids concurrently with the betamimetics, placebo or no treatment compared with studies that did not mention the use of steroids routinely or where steroid administration rate was reported as 50% or less. </p> <p>Subgroup analysis was restricted to the review’s primary outcomes.</p> <p>We planned to assess differences between subgroups by interaction tests available in RevMan. </p> </section> <section id="CD004352-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>For primary outcomes we carried out sensitivity analysis by risk of bias, temporarily excluding trials with unclear or high risk of bias for allocation concealment from the analysis to examine the impact on results. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004352-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004352-sec-0059"></div> <section id="CD004352-sec-0060"> <h3 class="title">Description of studies</h3> <p>One hundred and five reports were identified by the search strategy, equating to 93 separate studies (some trials resulted in multiple publications). Of these 93 studies, 28 were eligible for inclusion, although findings are based on 20 trials which contributed data. Eight trials that were otherwise eligible for inclusion did not report outcomes relevant to the review, and did not contribute data. Further information on these trials is set out in <a href="./references#CD004352-sec-0117" title="">Characteristics of included studies</a> tables but they are not otherwise discussed in the results below (<a href="./references#CD004352-bbs2-0012" title="KovacsVL , MeszarosG , PalA , SzaszK . Tocolysis with clenbuterol tablets. Zentralblatt fur Gynakologie1987;109:1368‐73. ">Kovacs 1987</a>; <a href="./references#CD004352-bbs2-0013" title="KullanderS , SvanbergL . On resorption and the effects of vaginally administered terbutaline in women with premature labor. Acta Obstetricia et Gynecologica Scandinavica1985;64:613‐6. ">Kullander 1985</a>; <a href="./references#CD004352-bbs2-0019" title="PasargiklianR , MontiG , BertulessiC . Clenbuterol in the treatment of premature labor. Minerva Ginecologica1983;35:423‐9. ">Pasargiklian 1983</a>; <a href="./references#CD004352-bbs2-0020" title="PenneyLL , DaniellWC . Estimation of success in treatment of premature labor: applicability of prolongation index in a double‐blind, controlled, randomized trial. American Journal of Obstetrics and Gynecology1980;138:345‐6. ">Penney 1980</a>; <a href="./references#CD004352-bbs2-0021" title="PhilipsenT , EriksenPS , LynggardF . Pulmonary edema following ritodrine‐saline infusion in premature labor. Obstetrics &amp; Gynecology1981;58:304‐8. ">Philipsen 1981</a>; <a href="./references#CD004352-bbs2-0023" title="SpellacyWN . The effects of ritodrine on maternal metabolism. Gynecologic Investigation1974;5:42. ">Spellacy 1974</a>; <a href="./references#CD004352-bbs2-0024" title="SpellacyWN , CruzAC , BuhiWC , BirkSA . The acute effects of ritodrine infusion on maternal metabolism: measurements of levels of glucose, insulin, glucagon, triglycerides, cholesterol, placental lactogen, and chorionic gonadotropin. American Journal of Obstetrics and Gynecology1978;131:637‐42. ">Spellacy 1978</a>; <a href="./references#CD004352-bbs2-0026" title="ThoulonJM , DelecourM , KellerB , LeratMF , PuechF , SchweitzerR , et al. Multicenter comparison between two doses of IV ritodrine infusion in the management of premature labors. Proceedings of 8th European Congress of Perinatal Medicine; 1982 September 7‐10; Brussels, Belgium. 1982:153. ">Thoulon 1982</a>). </p> <p>Sixty‐four trials were excluded and one is awaiting classification pending further information from the trial authors. </p> <section id="CD004352-sec-0061"> <h4 class="title">Excluded studies</h4> <p>Trials were excluded for the following reasons: method of generation of allocation was not truly randomised or inadequate (<a href="./references#CD004352-bbs2-0035" title="CalderAA , PatelNB . Are betamimetics worthwhile in preterm labour?. In: BeardRW , SharpF editor(s). Preterm Labour and its Consequences. Proceedings of the 13th Study Group of the Royal College of Obstetricians and Gynaecologists. London: RCOG, 1985:209‐18. ">Calder 1985</a>; <a href="./references#CD004352-bbs2-0037" title="CaritisSN , CotroneoM , HeckmanL , ChiaoJP . A comparison of side effects with two ritodrine infusion regimens. American Journal of Obstetrics and Gynecology1991;164:294. ">Caritis 1991</a>; <a href="./references#CD004352-bbs2-0038" title="CastilloJ , AlonsoJ , Hernandez‐GarciaJ , SanchoB , MartinezV . Study of biochemical and biophysical modifications produced on pregnant women treated in threatened of premature labor with ritodrine and indometacine. World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:20. ">Castillo 1988</a>; <a href="./references#CD004352-bbs2-0039" title="CastrenO , GummerusM , SaarikoskiS . Treatment of imminent premature labour. Acta Obstetricia et Gynecologica Scandinavica1975;54:95‐100. ">Castren 1975</a>; <a href="./references#CD004352-bbs2-0040" title="ChhabraS , PatilN . Double blind study of efficacy of isoxsuprine and ritodrine in arrest of preterm labour. Prenatal and Neonatal Medicine1998;3 Suppl 1:202. ">Chhabra 1998</a>; <a href="./references#CD004352-bbs2-0042" title="CsapoAI , HerczegJ . Arrest of premature labor by isoxsuprine. American Journal of Obstetrics and Gynecology1977;129:482‐8. ">Csapo 1977</a>; <a href="./references#CD004352-bbs2-0043" title="DasRK . Isoxsuprine in premature labour. Journal of Obstetrics and Gynaecology of India1969;19:566‐70. ">Das 1969</a>; <a href="./references#CD004352-bbs2-0052" title="GonikB , BenedettiT , CreasyRK , LeeAFS . Intramuscular vs intravenous ritodrine hydrochloride for preterm labor management. American Journal of Obstetrics and Gynecology1988;159:323‐8. ">Gonik 1988</a>; <a href="./references#CD004352-bbs2-0054" title="GummerusM . The management of premature labor with salbutamol. Acta Obstetricia et Gynecologica Scandinavica1981;60:375‐7. ">Gummerus 1981</a>; <a href="./references#CD004352-bbs2-0062" title="KarlssonK , KrantzM , HambergerL . Comparison of various betamimetics on preterm labor, survival and development of the child. Journal of Perinatal Medicine1980;8:19‐26. ">Karlsson 1980</a>; <a href="./references#CD004352-bbs2-0064" title="KimMH , SchBH , LeeJH . The clinical study of ritodrine hydrochloride (Yutopar). Effect on preterm labour. Korean Journal of Obstetrics &amp; Gynecology1983;26:23‐32. ">Kim 1983</a>; <a href="./references#CD004352-bbs2-0065" title="KosasaTS , NakayamaRT , HaleRW , RinzlerGS , FreitasCA . Ritodrine and terbutaline compared for the treatment of preterm labor. Acta Obstetricia et Gynecologica Scandinavica1985;64:421‐6. ">Kosasa 1985</a>; <a href="./references#CD004352-bbs2-0068" title="LenzS , DetlefsenG , RygaardC , VejerslevL . Isotonic dextrose and isotonic saline as solvents for intravenous treatment of premature labour with ritodrine. Journal of Obstetrics and Gynaecology1985;5:151‐4. ">Lenz 1985</a>; <a href="./references#CD004352-bbs2-0075" title="ParkIS , KimYC , ParkHM , ChaIS . Effect of ritodrine hydrochloride (Yutopar) on premature labor. Korean Journal of Obstetrics &amp; Gynecology1982;25:935‐44. ">Park 1982</a>; <a href="./references#CD004352-bbs2-0079" title="RichterR , HammacherK , HinselmannM . Prophylaxis of threatened premature labour. Clinical results in a prospective comparative study with ritodrine and buphenine. Gynakologische Rundschau1975;15:58‐9. ">Ritcher 1975</a>; <a href="./references#CD004352-bbs2-0082" title="RydenG . The effect of salbutamol and terbutaline in the management of premature labour. Acta Obstetricia et Gynecologica Scandinavica1977;56:293‐6. ">Ryden 1977</a>; <a href="./references#CD004352-bbs2-0084" title="SciscioneA , GormanR , SchlossmanP , ColmorganG . A randomized prospective study of intravenous magnesium sulfate, ritrodine, and subcutaneous terbutaline as treatments for preterm labor. American Journal of Obstetrics and Gynecology1993;168:376. ">Sciscione 1993</a>; <a href="./references#CD004352-bbs2-0085" title="SirohiwalD , SachanA , BanoA , GulatiN . Tocolysis with ritodrine: a comparative study in preterm labour. Journal of Obstetrics and Gynecology of India2001;51(3):66‐7. ">Sirohiwal 2001</a>; <a href="./references#CD004352-bbs2-0086" title="SivasambooR . Premature labour. Proceedings of International Symposium on the Treatment of Fetal Risks; 1972 May; Baden, Austria. 1972:16‐20. ">Sivasamboo 1972</a>; <a href="./references#CD004352-bbs2-0087" title="SpatlingL , FallensteinF , SchneiderH , DancisJ . Bolus tocolysis: treatment of preterm labor with pulsatile administration of a beta‐adrenergic agonist. American Journal of Obstetrics and Gynecology1989;160:713‐7. ">Spatling 1989</a>; <a href="./references#CD004352-bbs2-0090" title="WeisbachW , WagnerF , JagerKH . Oral long term tocolysis in threatening preterm delivery with Clenbuterol (Contraspasmin r, Spiropent r). A randomized clinical trial [Orale Langzeittokolyse der drohenden Fruhgebert mit Clebuterol (Contraspasmin r, Spiropent r). Eine plazebokontrolliert Doppelblindstudie]. Zentralblatt fur Gynakologie1986;108:419‐23. ">Weisbach 1986</a>; <a href="./references#CD004352-bbs2-0092" title="ZellerG , DudenhausenJW . Indications for tocolysis. A prospective study. Zentralblatt fur Gynakologie1986;108:1473‐81. ">Zeller 1986</a>); it was not clear that all participants were in preterm labour (<a href="./references#CD004352-bbs2-0045" title="DunlopPDM , CrowleyPA , LamontRF , HawkinsDF . Preterm ruptured membranes, no contractions. Journal of Obstetrics and Gynaecology1986;7:92‐6. ">Dunlop 1986</a>; <a href="./references#CD004352-bbs2-0053" title="GuinnD , GeopfertA , OwenJ , BrumfieldC , HauthJ . Management options in women with preterm uterine contractions: a randomized clinical trial. American Journal of Obstetrics and Gynecology1997;177(4):814‐8. GuinnD , GoepfertA , OwenJ , BrumfieldC , HauthJ . Management options in women with preterm uterine contractions: a randomized clinical trial. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S44. ">Guinn 1997</a>; <a href="./references#CD004352-bbs2-0055" title="HallakM , MoiseKJ , LiraN , DormanK , O'Brian SmithE , CottonDB . The effect of tocolytic agents (indomethacin and terbutaline) on fetal breathing (FBM) and body movements (FM): a prospective, randomized, double blind, placebo‐controlled clinical trial. American Journal of Obstetrics and Gynecology1992;166:375. HallakM , MoiseKJ , LiraN , DormanKF , SmithEO , CottonDB . The effect of tocolytic agents (indomethacin and terbutaline) on fetal breathing and body movements: a prospective, randomized, double‐blind, placebo‐controlled clinical trial. American Journal of Obstetrics and Gynecology1992;167:1059‐63. ">Hallak 1992</a>; <a href="./references#CD004352-bbs2-0056" title="HallakM , MoiseKJ , O'Brian SmithE , CottonDB . The effects of indomethacin and terbutaline on human fetal umbilical artery velocimetry: a randomized, double‐blind study. American Journal of Obstetrics and Gynecology1993;168:348. HallakM , MoiseKJ , O'Brian SmithE , CottonDB . The effects of indomethacin and terbutaline on human fetal umbilical artery velocimetry: a randomized, double‐blind study. American Journal of Obstetrics and Gynecology1993;168:865‐8. ">Hallak 1993</a>; <a href="./references#CD004352-bbs2-0067" title="LeakeRD , HobelCJ , OhW , ThibeaultDW , OkadaDM , WilliamsPR . A controlled, prospective study of the effect of ritodrine hydrochloride (r) for premature labor. Pediatric Research1980;14:603. LeakeRD , HobelCJ , OhW , ThibeaultDW , OkadaDM , WilliamsPR . A controlled, prospective study of the effects of ritodrine hydrochloride for premature labor. Clinical Research1980;28:90A. LeakeRD , HobelCJ , OkadaDM , RossMG , WilliamsPR . Neonatal metabolic effects of oral ritodrine hydrochloride administration. Pediatric Pharmacology1983;3:101‐6. ">Leake 1983</a>; <a href="./references#CD004352-bbs2-0069" title="LevyDL , WarsofSL . Oral ritodrine and preterm premature rupture of membranes. Obstetrics &amp; Gynecology1985;66:621‐3. ">Levy 1985</a>; <a href="./references#CD004352-bbs2-0070" title="LipshitzJ , BaillieP , DaveyDA . A comparison of the uterine beta2‐adrenoreceptor selectivity of fenoterol, hexoprenaline, ritodrine and salbutamol. South African Medical Journal1976;50:1969‐72. ">Lipshitz 1976</a>; <a href="./references#CD004352-bbs2-0073" title="Muller‐HolveW , HermerM , KlockFK , KreisM , BrehmH , ElserH , et al. Fenoterol depot and fenoterol in premature uterine contractions ‐ a multicentric double‐blind comparative study. Journal of Perinatal Medicine1987;15:95‐103. ">Muller‐Holve 1987</a>; <a href="./references#CD004352-bbs2-0083" title="SanchezPD , ReneA , CarrerasM , CaberoL , SostoaM , GamissansO , et al. Orciprenaline and ritodrine. A comparative study. Proceedings of International Symposium on the Treatment of Fetal Risks; 1972 May; Baden, Austria. 1972:15. ">Sanchez 1972</a>; <a href="./references#CD004352-bbs2-0088" title="Tarnow‐MordiWO . Prevention of early respiratory illness by antepartum betamimetic therapy (PERINAT 1). Personal communication1988. ">Tarnow‐Mordi 1988</a>); the interventions were not consistent with the protocol (<a href="./references#CD004352-bbs2-0029" title="AllyK , NicolasA , ThoumsinH , LambotteR . Magnesium gluconate and intravenous tocolysis with ritrodrine. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1992;21:370‐4. ">Ally 1992</a>; <a href="./references#CD004352-bbs2-0031" title="BedoyaJM . Use of orciprenaline in the treatment of threatened premature labour. Proceedings of International Symposium on the Treatment of Fetal Risks; 1972 May; Baden, Austria. 1972:27‐9. ">Bedoya 1972</a>; <a href="./references#CD004352-bbs2-0032" title="BesingerRE , NiebylJR , KeyesWG , JohnsonTRB . Randomized comparative trial of indomethacin and ritodrine for the long‐term treatment of preterm labor. American Journal of Obstetrics and Gynecology1991;164:981‐8. ">Besinger 1991</a>; <a href="./references#CD004352-bbs2-0033" title="Bulgay‐MoerschelM , SchneiderU , SchleussnerE . Tocolysis with nitroglycerin patches vs. fenoterol i.v. ‐ results of a randomized multicenter study. Journal of Maternal‐Fetal and Neonatal Medicine2008;21(Suppl 1):115. ">Bulgay‐Moerschel 2008</a>; <a href="./references#CD004352-bbs2-0034" title="CaballeroA , TejerinaA , DominguezA , NavaJM , CaballeroAJr . Indomethacine alone or associated to ritodrine in the prevention of premature labour [abstract]. 9th World Congress of Gynecology and Obstetrics; 1979 Oct 26‐31;Tokyo, Japan. 1979:300. ">Caballero 1979</a>; <a href="./references#CD004352-bbs2-0036" title="CararachV , PalacioM , MartinezS , DeulofeuP , SanchezM , CoboT , et al. Nifedipine versus ritodrine for suppression of preterm labor. Comparison of their efficacy and secondary effects. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2006;127(2):204‐8. ">Cararach 2006</a>; <a href="./references#CD004352-bbs2-0044" title="DellenbachP , VorsJ , MullerP . Experimentation, during labor, of a utero‐relaxing agent by the double blind method. Results on the use of a computer in 523 cases. Bulletin de la Federation des Societes de Gynecologie et d Obstetrique de Langue Francaise1971;23:116‐8. ">Dellenbach 1971</a>; <a href="./references#CD004352-bbs2-0046" title="FergusonJEII , HolbrookH , StevensonDK , HensleighPA , KredentserD . Adjunctive magnesium sulfate infusion does not alter metabolic changes associated with ritodrine tocolysis. American Journal of Obstetrics and Gynecology1987;156:103‐7. ">Ferguson 1987</a>; <a href="./references#CD004352-bbs2-0047" title="FrancioliM , DeMeuronA . Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened premature labor. Revue Medicale de la Suisse Romande1988;108:283‐9. ">Francioli 1988</a>; <a href="./references#CD004352-bbs2-0048" title="GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:123‐8. GamissansO , CanasE , CararachV , RibasJ , PuertoB , EdoA . A study of indomethacin combined with ritodrine in threatened preterm labor. Proceedings of 6th European Congress of Perinatal Medicine; 1978 Aug 29‐Sept 1; Vienna, Austria. 1978:165. ">Gamissans 1978</a>; <a href="./references#CD004352-bbs2-0049" title="GamissansO , CararachV , SerraJ . The role of prostaglandin‐inhibitors, beta‐adrenergic drugs and glucocorticoids in the management of threatened preterm labor. Beta‐mimetic drugs in obstetrics and perinatology. 3rd Symposium on beta‐mimetic drugs; 1980 Nov; Aachen. Stuttgart: Georg Thieme, 1982:71‐84. ">Gamissans 1982</a>; <a href="./references#CD004352-bbs2-0051" title="GoelS , Sunayna , ShrivastavaD , MukharjeeS . Comparison of micronised progesterone with isoxupurine in management of pre term labour. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5‐9; Hyderabad, Andhra Pradesh, India. 2011:305. ">Goel 2011</a>; <a href="./references#CD004352-bbs2-0057" title="HatjisCG , SwainM , NelsonLH , MeisPJ , ErnestJM . Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstetrics &amp; Gynecology1978;69:317‐22. ">Hatjis 1987</a>; <a href="./references#CD004352-bbs2-0058" title="HerzogS , CunzeT , MartinM , OsmersR , GleiterC , KuhnW . Pulsatile vs. continuous parenteral tocolysis: comparison of side effects. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1999;85:199‐204. HerzogS , CunzeT , OsmersR , KuhnW . Comparative study of maternal side effects of various forms of intravenous therapy with fenoterol in premature labor. Gynakologisch‐Geburtshilfliche Rundschau1995;35(1):73‐9. ">Herzog 1995</a>; <a href="./references#CD004352-bbs2-0060" title="IedaK , SasakiJ , MizunoS , MimuraS , SuzukiC , MiyazakiT , et al. The clinical effects of maternally administered magnesium sulfate on the neonate. Journal of Perinatal Medicine1991;2:225S. ">Ieda 1991</a>; <a href="./references#CD004352-bbs2-0061" title="KanayamaN , elMaradnyE , YamamotoN , TokunagaN , MaeharaK , TeraoT . Urinary trypsin inhibitor: a new drug to treat preterm labor: a comparative study with ritodrine. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1996;67(2):133‐8. ">Kanayama 1996</a>; <a href="./references#CD004352-bbs2-0063" title="KatzZ , LancetM , YeminiM , MogilnerBM , FeiglA , Ben‐HurH . Treatment of premature labor contractions with combined ritodrine and indomethacine. International Journal of Gynecology &amp; Obstetrics1983;21:337‐42. ">Katz 1983</a>; <a href="./references#CD004352-bbs2-0071" title="LyellD , PullenK , CampbellL , ChingS , BurrsD , ChitkaraU , et al. Magnesium sulfate versus nifedipine for acute tocolysis of preterm labor [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S18. ">Lyell 2005</a>; <a href="./references#CD004352-bbs2-0074" title="NeriI , MonariF , ValensiseH , VasapolloB , FacchinettiF , VolpeA . Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine. American Journal of Perinatology2009;26(4):259‐63. ">Neri 2009</a>; <a href="./references#CD004352-bbs2-0076" title="RaymajhiR , PratapK . A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour. Kathmandu University Medical Journal2003;1(2):85‐90. ">Raymajhi 2003</a>; <a href="./references#CD004352-bbs2-0077" title="ReynoldsJW . A comparison of salbutamol and ethanol in the treatment of premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1978;18:107‐9. ">Reynolds 1978</a>; <a href="./references#CD004352-bbs2-0078" title="Rios‐AnezR , Santos‐LuqueM , NogueraM . Use of an antagonist of the prostaglandins associated to a b‐sympathomimetic agent in the treatment of pre‐term labour [abstract]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):165. ">Rios‐Anez 2001</a>; <a href="./references#CD004352-bbs2-0080" title="RichterR , HinselmannMJ . The treatment of threatened premature labor by betamimetic drugs: a comparison of fenoterol and ritodrine. Obstetrics &amp; Gynecology1979;53:81‐7. ">Ritcher 1979</a>; <a href="./references#CD004352-bbs2-0081" title="RossMG , NicollsE , StubblefieldPG , KitzmillerJL . Intravenous terbutaline and simultaneous beta‐blockade for advanced premature labor. American Journal of Obstetrics and Gynecology1983;147:897‐902. ">Ross 1983</a>; <a href="./references#CD004352-bbs2-0089" title="TrabelsiK , Hadj TaibH , AmouriH , AbdennadheurW , Ben AmarH , KallelW , et al. Nicardipine versus salbutamol in the treatment of premature labor: comparison of their efficacy and side effects. Tunisie Medicale2008;86(1):43‐8. ">Trabelsi 2008</a>); some of the comparisons examined in these trials are examined in other Cochrane reviews. Loss to follow‐up exceeded 20% in one study (<a href="./references#CD004352-bbs2-0030" title="BeallMH , EdgarBW , PaulRH , Smith‐WallaceT . A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. American Journal of Obstetrics and Gynecology1985;153:854‐9. ">Beall 1985</a>), and one paper reported results from a series of trials which were reported individually in included studies (<a href="./references#CD004352-bbs2-0072" title="MerkatzIR , PeterJB , BardenTP . Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. II. Evidence of efficacy. Obstetrics &amp; Gynecology1980;56(1):7‐12. ">Merkatz 1980</a>). </p> <p>In addition, some studies, which were included in the previous versions of the review, were excluded from this updated version due to several reasons: loss to follow‐up 20% or more (<a href="./references#CD004352-bbs2-0050" title="GariteTJ , KeeganKA , FreemanRK , NageotteMP . A randomized trial of ritodrine tocolysis vs expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. American Journal of Obstetrics and Gynecology1987;157:388‐93. ">Garite 1987</a>; <a href="./references#CD004352-bbs2-0059" title="HowardTE , KillamAP , PenneyLL , DaniellWC . A double blind randomized study of terbutaline in premature labor. Military Medicine1982;147:305‐7. ">Howard 1982</a>; <a href="./references#CD004352-bbs2-0066" title="LarsenJF , EldonK , LangeAP , LeegaardM , OslerM , Sederberg OlsenJ , et al. Ritodrine in the treatment of preterm labor: second Danish multicenter study. Obstetrics &amp; Gynecology1986;67:607‐13. ">Larsen 1986</a>); conducted in preterm premature rupture of membranes without preterm labour (<a href="./references#CD004352-bbs2-0041" title="ChristensenKK , IngemarssonI , LeidemanT , SolumH , SvenningsenN . Effect of ritodrine on labor after premature rupture of the membranes. Obstetrics &amp; Gynecology1980;55:187‐90. ">Christensen 1980</a>); and data were reported by episode of preterm labour (<a href="./references#CD004352-bbs2-0091" title="Wesselius‐De CasparisA , ThieryM , Yo Le SianA , BaumgartenK , BrosensI , GamissansO , et al. Results of double‐blind, multicentre study with ritodrine in premature labour. British Medical Journal1971;3:144‐7. ">Wesselius‐De 1971</a>). </p> <p>Please <i>see</i> table of <a href="./references#CD004352-sec-0118" title="">Characteristics of excluded studies</a> for further details. </p> </section> <section id="CD004352-sec-0062"> <h4 class="title">Included studies</h4> <p>Twenty randomised controlled trials examining the effect of betamimetics for inhibiting preterm labour contributed data to the review. </p> <p>A total of 1367 women participated in the 12 included trials comparing betamimetics with placebo or no treatment (<a href="./references#CD004352-bbs2-0001" title="AdamGS . Isoxuprine and premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1966;6:294‐8. ">Adam 1966</a>; <a href="./references#CD004352-bbs2-0002" title="BardenTP . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1990. ">Barden 1980</a>; <a href="./references#CD004352-bbs2-0004" title="CottonDB , StrassnerHT , HillLM , SchifrinBS , PaulRH . Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine1984;29:92‐7. ">Cotton 1984</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0009" title="HobelCJ . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Hobel 1980</a>; <a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>; <a href="./references#CD004352-bbs2-0014" title="HesseldahlH . A Danish multicenter study on Ritodrine r in the treatment of pre‐term labour. Danish Medical Bulletin1979;26:116‐8. KristoffersenK , HansenMK . The condition of the foetus and infant in cases treated with Ritodrine r. Danish Medical Bulletin1979;26:121‐2. LarsenJF , HansenMK , HesseldahlH , KristoffersenK , LarsenPK , OslerM , et al. Ritodrine in the treatment of preterm labour ‐ a clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. British Journal of Obstetrics and Gynaecology1980;87:949‐57. OslerM . Side effects and metabolic changes during treatment with betamimetics (Ritodrine r). Danish Medical Bulletin1979;26:119‐20. ">Larsen 1980</a>; <a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>; <a href="./references#CD004352-bbs2-0017" title="MarionaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Mariona 1980</a>; <a href="./references#CD004352-bbs2-0022" title="ScommegnaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Scommegna 1980</a>; <a href="./references#CD004352-bbs2-0025" title="SpellacyWN , CruzAC , BirkSA , BuhiWC . Treatment of premature labour with ritodrine: a randomized controlled study. Obstetrics &amp; Gynecology1979;54:220‐3. ">Spellacy 1979</a>; <a href="./references#CD004352-bbs2-0027" title="Tohoku Research Group for Prevention of Preterm Birth. Effectiveness of ritodrine hydrochloride for tocolysis in threatened preterm delivery ‐ double blinded trial. Igaku no Ayumi1984;131(4):270‐8. ">Tohoku 1984</a>). Data for four trials (<a href="./references#CD004352-bbs2-0002" title="BardenTP . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1990. ">Barden 1980</a>; <a href="./references#CD004352-bbs2-0009" title="HobelCJ . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Hobel 1980</a>; <a href="./references#CD004352-bbs2-0017" title="MarionaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Mariona 1980</a>; <a href="./references#CD004352-bbs2-0022" title="ScommegnaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Scommegna 1980</a>) were included in a previous version of the review (<a href="./references#CD004352-bbs2-0106" title="KingJF , GrantA , KeirseMJNC , ChalmersI . Beta‐mimetics in preterm labour: an overview of the randomized controlled trials. British Journal of Obstetrics and Gynaecology1988;95:211‐22. ">King 1988</a>) and were extracted from personal communications from trial authors. </p> <p>A further 948 women participated in the five trials of comparing other betamimetics with ritodrine (<a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0007" title="EssedGGM , EskesTKAB , JongsmaHW . A randomized trial of two beta‐mimetic drugs for the treatment of threatening early labor. Clinical results in a prospective comparative study with ritodrine and fenoterol. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:341‐8. ">Essed 1978</a>; <a href="./references#CD004352-bbs2-0010" title="HolleboomCAG , MerkusJMWM , vanElferenLWM , KeirseMJNC . Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. British Journal of Obstetrics and Gynaecology1996;103:695‐701. ">Holleboom 1996</a>; <a href="./references#CD004352-bbs2-0016" title="LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ . Comparison of the cardiovascular effects of hexoprenaline and ritodrine in the treatment of preterm labor. Proceedings of 3rd Annual Meeting of Society of Perinatal Obstetricians; 1983 January; San Antonio, Texas, USA. 1983:13. LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ , et al. Comparison of hexoprenaline and ritodrine in the treatment of preterm labor: United States multicenter study. Proceedings of 11th European Congress of Perinatal Medicine; 1988 April 10‐13; Rome, Italy. 1988. ">Lipshitz 1988</a>; <a href="./references#CD004352-bbs2-0028" title="BradenG , VonOeyenP , GermainM , WatsonD , HaagB . Ritodrine‐ and terbutaline‐induced hypokalemia in preterm labor: mechanisms and consequences. Kidney International1997;51:1867‐75. VonOeyenP , BradenG , SmithM , GarbJ , LiucciL . A randomized study comparing ritodrine and terbutaline for the treatment of preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:186. ">Von Oeyen 1990</a>); in two of these trials results were reported in brief abstracts only (<a href="./references#CD004352-bbs2-0016" title="LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ . Comparison of the cardiovascular effects of hexoprenaline and ritodrine in the treatment of preterm labor. Proceedings of 3rd Annual Meeting of Society of Perinatal Obstetricians; 1983 January; San Antonio, Texas, USA. 1983:13. LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ , et al. Comparison of hexoprenaline and ritodrine in the treatment of preterm labor: United States multicenter study. Proceedings of 11th European Congress of Perinatal Medicine; 1988 April 10‐13; Rome, Italy. 1988. ">Lipshitz 1988</a>; <a href="./references#CD004352-bbs2-0028" title="BradenG , VonOeyenP , GermainM , WatsonD , HaagB . Ritodrine‐ and terbutaline‐induced hypokalemia in preterm labor: mechanisms and consequences. Kidney International1997;51:1867‐75. VonOeyenP , BradenG , SmithM , GarbJ , LiucciL . A randomized study comparing ritodrine and terbutaline for the treatment of preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:186. ">Von Oeyen 1990</a>). </p> <p>One trial with 140 women compared hexoprenaline and salbutamol (<a href="./references#CD004352-bbs2-0008" title="GummerusM . Tocolysis with hexoprenalin and salbutamol in clinical comparison. Geburtshilfe und Frauenheilkunde1983;43:151‐5. ">Gummerus 1983</a>), <a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a> compared terbutaline with salbutamol in a trial with 200 women, and <a href="./references#CD004352-bbs2-0006" title="CrepinG , DelcroixM , ParmentierD , AdamMH , RenonD , GeorgesD . Use of a slow‐release form of salbutamol in the treatment of threatened premature labor. A comparative study of 52 randomized cases compared with the immediate release form [Utilisation d'une forme 'retard' de Salbutamol dans le traitement des menaces d'accouchement premature. Etude comparative de 52 cas randomises avec la forme a liberation immediate]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18(8):1063‐7. ">Crepin 1989</a> (60 women) examined slow versus normal release salbutamol. </p> <section id="CD004352-sec-0063"> <h5 class="title">(1) Study location and settings</h5> <p>Trials were published over a 44‐year period between 1966 (<a href="./references#CD004352-bbs2-0001" title="AdamGS . Isoxuprine and premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1966;6:294‐8. ">Adam 1966</a>) and 2010 (<a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a>). Included studies were conducted in tertiary care or University hospitals in high‐income settings: trials were conducted in the USA (<a href="./references#CD004352-bbs2-0002" title="BardenTP . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1990. ">Barden 1980</a>; <a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0004" title="CottonDB , StrassnerHT , HillLM , SchifrinBS , PaulRH . Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine1984;29:92‐7. ">Cotton 1984</a>; <a href="./references#CD004352-bbs2-0009" title="HobelCJ . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Hobel 1980</a>; <a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>; <a href="./references#CD004352-bbs2-0016" title="LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ . Comparison of the cardiovascular effects of hexoprenaline and ritodrine in the treatment of preterm labor. Proceedings of 3rd Annual Meeting of Society of Perinatal Obstetricians; 1983 January; San Antonio, Texas, USA. 1983:13. LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ , et al. Comparison of hexoprenaline and ritodrine in the treatment of preterm labor: United States multicenter study. Proceedings of 11th European Congress of Perinatal Medicine; 1988 April 10‐13; Rome, Italy. 1988. ">Lipshitz 1988</a>; <a href="./references#CD004352-bbs2-0017" title="MarionaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Mariona 1980</a>; <a href="./references#CD004352-bbs2-0022" title="ScommegnaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Scommegna 1980</a>; <a href="./references#CD004352-bbs2-0025" title="SpellacyWN , CruzAC , BirkSA , BuhiWC . Treatment of premature labour with ritodrine: a randomized controlled study. Obstetrics &amp; Gynecology1979;54:220‐3. ">Spellacy 1979</a>; <a href="./references#CD004352-bbs2-0028" title="BradenG , VonOeyenP , GermainM , WatsonD , HaagB . Ritodrine‐ and terbutaline‐induced hypokalemia in preterm labor: mechanisms and consequences. Kidney International1997;51:1867‐75. VonOeyenP , BradenG , SmithM , GarbJ , LiucciL . A randomized study comparing ritodrine and terbutaline for the treatment of preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:186. ">Von Oeyen 1990</a>), Europe (<a href="./references#CD004352-bbs2-0006" title="CrepinG , DelcroixM , ParmentierD , AdamMH , RenonD , GeorgesD . Use of a slow‐release form of salbutamol in the treatment of threatened premature labor. A comparative study of 52 randomized cases compared with the immediate release form [Utilisation d'une forme 'retard' de Salbutamol dans le traitement des menaces d'accouchement premature. Etude comparative de 52 cas randomises avec la forme a liberation immediate]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18(8):1063‐7. ">Crepin 1989</a>; <a href="./references#CD004352-bbs2-0007" title="EssedGGM , EskesTKAB , JongsmaHW . A randomized trial of two beta‐mimetic drugs for the treatment of threatening early labor. Clinical results in a prospective comparative study with ritodrine and fenoterol. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:341‐8. ">Essed 1978</a>; <a href="./references#CD004352-bbs2-0008" title="GummerusM . Tocolysis with hexoprenalin and salbutamol in clinical comparison. Geburtshilfe und Frauenheilkunde1983;43:151‐5. ">Gummerus 1983</a>; <a href="./references#CD004352-bbs2-0010" title="HolleboomCAG , MerkusJMWM , vanElferenLWM , KeirseMJNC . Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. British Journal of Obstetrics and Gynaecology1996;103:695‐701. ">Holleboom 1996</a>; <a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>; <a href="./references#CD004352-bbs2-0014" title="HesseldahlH . A Danish multicenter study on Ritodrine r in the treatment of pre‐term labour. Danish Medical Bulletin1979;26:116‐8. KristoffersenK , HansenMK . The condition of the foetus and infant in cases treated with Ritodrine r. Danish Medical Bulletin1979;26:121‐2. LarsenJF , HansenMK , HesseldahlH , KristoffersenK , LarsenPK , OslerM , et al. Ritodrine in the treatment of preterm labour ‐ a clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. British Journal of Obstetrics and Gynaecology1980;87:949‐57. OslerM . Side effects and metabolic changes during treatment with betamimetics (Ritodrine r). Danish Medical Bulletin1979;26:119‐20. ">Larsen 1980</a>), Australia (<a href="./references#CD004352-bbs2-0001" title="AdamGS . Isoxuprine and premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1966;6:294‐8. ">Adam 1966</a>), Canada (<a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>), Iran (<a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a>) and Japan (<a href="./references#CD004352-bbs2-0027" title="Tohoku Research Group for Prevention of Preterm Birth. Effectiveness of ritodrine hydrochloride for tocolysis in threatened preterm delivery ‐ double blinded trial. Igaku no Ayumi1984;131(4):270‐8. ">Tohoku 1984</a>). Eight trials were multicentre studies. </p> </section> <section id="CD004352-sec-0064"> <h5 class="title">(2) Participants</h5> <p>The participants included in these trials were reasonably homogeneous. The gestational age at inclusion ranged from 20 to up to 37 weeks. Preterm labour was reasonably consistently defined across the trials as the presence of uterine contractions documented by external tocography or cervical dilatation up to 4 to 5 cm, or both, except for three trials, which did not state the definition (<a href="./references#CD004352-bbs2-0008" title="GummerusM . Tocolysis with hexoprenalin and salbutamol in clinical comparison. Geburtshilfe und Frauenheilkunde1983;43:151‐5. ">Gummerus 1983</a>; <a href="./references#CD004352-bbs2-0016" title="LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ . Comparison of the cardiovascular effects of hexoprenaline and ritodrine in the treatment of preterm labor. Proceedings of 3rd Annual Meeting of Society of Perinatal Obstetricians; 1983 January; San Antonio, Texas, USA. 1983:13. LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ , et al. Comparison of hexoprenaline and ritodrine in the treatment of preterm labor: United States multicenter study. Proceedings of 11th European Congress of Perinatal Medicine; 1988 April 10‐13; Rome, Italy. 1988. ">Lipshitz 1988</a>; <a href="./references#CD004352-bbs2-0028" title="BradenG , VonOeyenP , GermainM , WatsonD , HaagB . Ritodrine‐ and terbutaline‐induced hypokalemia in preterm labor: mechanisms and consequences. Kidney International1997;51:1867‐75. VonOeyenP , BradenG , SmithM , GarbJ , LiucciL . A randomized study comparing ritodrine and terbutaline for the treatment of preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:186. ">Von Oeyen 1990</a>). Three trials included women admitted for preterm labour with preterm premature rupture of membranes (<a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0004" title="CottonDB , StrassnerHT , HillLM , SchifrinBS , PaulRH . Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine1984;29:92‐7. ">Cotton 1984</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>) and three trials included twins (<a href="./references#CD004352-bbs2-0001" title="AdamGS . Isoxuprine and premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1966;6:294‐8. ">Adam 1966</a>; <a href="./references#CD004352-bbs2-0004" title="CottonDB , StrassnerHT , HillLM , SchifrinBS , PaulRH . Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine1984;29:92‐7. ">Cotton 1984</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>). Four trials did not state the exclusion criteria (<a href="./references#CD004352-bbs2-0007" title="EssedGGM , EskesTKAB , JongsmaHW . A randomized trial of two beta‐mimetic drugs for the treatment of threatening early labor. Clinical results in a prospective comparative study with ritodrine and fenoterol. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:341‐8. ">Essed 1978</a>; <a href="./references#CD004352-bbs2-0008" title="GummerusM . Tocolysis with hexoprenalin and salbutamol in clinical comparison. Geburtshilfe und Frauenheilkunde1983;43:151‐5. ">Gummerus 1983</a>; <a href="./references#CD004352-bbs2-0016" title="LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ . Comparison of the cardiovascular effects of hexoprenaline and ritodrine in the treatment of preterm labor. Proceedings of 3rd Annual Meeting of Society of Perinatal Obstetricians; 1983 January; San Antonio, Texas, USA. 1983:13. LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ , et al. Comparison of hexoprenaline and ritodrine in the treatment of preterm labor: United States multicenter study. Proceedings of 11th European Congress of Perinatal Medicine; 1988 April 10‐13; Rome, Italy. 1988. ">Lipshitz 1988</a>; <a href="./references#CD004352-bbs2-0028" title="BradenG , VonOeyenP , GermainM , WatsonD , HaagB . Ritodrine‐ and terbutaline‐induced hypokalemia in preterm labor: mechanisms and consequences. Kidney International1997;51:1867‐75. VonOeyenP , BradenG , SmithM , GarbJ , LiucciL . A randomized study comparing ritodrine and terbutaline for the treatment of preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:186. ">Von Oeyen 1990</a>). Most trials excluded those women with chorioamnionitis, pregnancy‐induced hypertension, vaginal bleeding, intrauterine compromise or fetal death, and contraindications to betamimetics. </p> </section> <section id="CD004352-sec-0065"> <h5 class="title">(3) Interventions</h5> <p>Nine trials compared ritodrine with placebo (<a href="./references#CD004352-bbs2-0002" title="BardenTP . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1990. ">Barden 1980</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0009" title="HobelCJ . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Hobel 1980</a>; <a href="./references#CD004352-bbs2-0014" title="HesseldahlH . A Danish multicenter study on Ritodrine r in the treatment of pre‐term labour. Danish Medical Bulletin1979;26:116‐8. KristoffersenK , HansenMK . The condition of the foetus and infant in cases treated with Ritodrine r. Danish Medical Bulletin1979;26:121‐2. LarsenJF , HansenMK , HesseldahlH , KristoffersenK , LarsenPK , OslerM , et al. Ritodrine in the treatment of preterm labour ‐ a clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. British Journal of Obstetrics and Gynaecology1980;87:949‐57. OslerM . Side effects and metabolic changes during treatment with betamimetics (Ritodrine r). Danish Medical Bulletin1979;26:119‐20. ">Larsen 1980</a>; <a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>; <a href="./references#CD004352-bbs2-0017" title="MarionaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Mariona 1980</a>; <a href="./references#CD004352-bbs2-0022" title="ScommegnaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Scommegna 1980</a>; <a href="./references#CD004352-bbs2-0025" title="SpellacyWN , CruzAC , BirkSA , BuhiWC . Treatment of premature labour with ritodrine: a randomized controlled study. Obstetrics &amp; Gynecology1979;54:220‐3. ">Spellacy 1979</a>, <a href="./references#CD004352-bbs2-0027" title="Tohoku Research Group for Prevention of Preterm Birth. Effectiveness of ritodrine hydrochloride for tocolysis in threatened preterm delivery ‐ double blinded trial. Igaku no Ayumi1984;131(4):270‐8. ">Tohoku 1984</a>). Intravenous ritodrine was used initially and maintained orally in all trials except one (<a href="./references#CD004352-bbs2-0014" title="HesseldahlH . A Danish multicenter study on Ritodrine r in the treatment of pre‐term labour. Danish Medical Bulletin1979;26:116‐8. KristoffersenK , HansenMK . The condition of the foetus and infant in cases treated with Ritodrine r. Danish Medical Bulletin1979;26:121‐2. LarsenJF , HansenMK , HesseldahlH , KristoffersenK , LarsenPK , OslerM , et al. Ritodrine in the treatment of preterm labour ‐ a clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. British Journal of Obstetrics and Gynaecology1980;87:949‐57. OslerM . Side effects and metabolic changes during treatment with betamimetics (Ritodrine r). Danish Medical Bulletin1979;26:119‐20. ">Larsen 1980</a>), which used intramuscular ritodrine initially. The dosage was consistent both intravenously and orally. Ritodrine was usually started at 100 mcg/minute and increased by 50 mcg/minute up to a maximum of 350 mcg/minute, or until contractions ceased, or there were intolerable adverse effects. Two trials compared terbutaline with placebo (<a href="./references#CD004352-bbs2-0004" title="CottonDB , StrassnerHT , HillLM , SchifrinBS , PaulRH . Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine1984;29:92‐7. ">Cotton 1984</a>; <a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>); the same regimen for intravenous infusion was used but oral terbutaline was only given in one trial (<a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>). One trial compared isoxsuprine with placebo (<a href="./references#CD004352-bbs2-0001" title="AdamGS . Isoxuprine and premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1966;6:294‐8. ">Adam 1966</a>). Two trials compared terbutaline with ritodrine (<a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0028" title="BradenG , VonOeyenP , GermainM , WatsonD , HaagB . Ritodrine‐ and terbutaline‐induced hypokalemia in preterm labor: mechanisms and consequences. Kidney International1997;51:1867‐75. VonOeyenP , BradenG , SmithM , GarbJ , LiucciL . A randomized study comparing ritodrine and terbutaline for the treatment of preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:186. ">Von Oeyen 1990</a>). Only one trial compared other betamimetics with ritodrine: fenoterol with ritodrine (<a href="./references#CD004352-bbs2-0007" title="EssedGGM , EskesTKAB , JongsmaHW . A randomized trial of two beta‐mimetic drugs for the treatment of threatening early labor. Clinical results in a prospective comparative study with ritodrine and fenoterol. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:341‐8. ">Essed 1978</a>); ritodrine loading dose with incremental dose (<a href="./references#CD004352-bbs2-0010" title="HolleboomCAG , MerkusJMWM , vanElferenLWM , KeirseMJNC . Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. British Journal of Obstetrics and Gynaecology1996;103:695‐701. ">Holleboom 1996</a>); and hexoprenaline with ritodrine (<a href="./references#CD004352-bbs2-0016" title="LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ . Comparison of the cardiovascular effects of hexoprenaline and ritodrine in the treatment of preterm labor. Proceedings of 3rd Annual Meeting of Society of Perinatal Obstetricians; 1983 January; San Antonio, Texas, USA. 1983:13. LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ , et al. Comparison of hexoprenaline and ritodrine in the treatment of preterm labor: United States multicenter study. Proceedings of 11th European Congress of Perinatal Medicine; 1988 April 10‐13; Rome, Italy. 1988. ">Lipshitz 1988</a>). An additional study compared hexoprenaline with salbutamol (<a href="./references#CD004352-bbs2-0008" title="GummerusM . Tocolysis with hexoprenalin and salbutamol in clinical comparison. Geburtshilfe und Frauenheilkunde1983;43:151‐5. ">Gummerus 1983</a>) while <a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a> compared terbutaline with salbutamol, and <a href="./references#CD004352-bbs2-0006" title="CrepinG , DelcroixM , ParmentierD , AdamMH , RenonD , GeorgesD . Use of a slow‐release form of salbutamol in the treatment of threatened premature labor. A comparative study of 52 randomized cases compared with the immediate release form [Utilisation d'une forme 'retard' de Salbutamol dans le traitement des menaces d'accouchement premature. Etude comparative de 52 cas randomises avec la forme a liberation immediate]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18(8):1063‐7. ">Crepin 1989</a> compared slow with normal release salbutamol. </p> </section> <section id="CD004352-sec-0066"> <h5 class="title">(4) Outcomes</h5> <p>There was some inconsistency across the trials with regards to the way in which outcomes were reported. Only three common primary outcomes were consistently reported: birth within 48 hours, perinatal death, and respiratory distress syndrome. However, the definition of respiratory distress syndrome was not stated. Only the biggest trial reported neonatal outcomes both in the short‐ and long‐term (<a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>). Secondary outcomes were less consistently reported and definitions were not stated. Mainly cardiovascular adverse effects from betamimetics were reported, particularly when treatment was stopped due to adverse reactions. Other adverse effects were less consistently reported. </p> <p>Please <i>see</i> tables of <a href="./references#CD004352-sec-0117" title="">Characteristics of included studies</a> for further details. </p> </section> </section> </section> <section id="CD004352-sec-0067"> <h3 class="title">Risk of bias in included studies</h3> <p>Summaries of 'Risk of bias' assessments for individual included studies, and for all studies are set out in <a href="#CD004352-fig-0001">Figure 1</a> and <a href="#CD004352-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD004352-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004352-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD004352-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004352-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD004352-sec-0068"> <h4 class="title">Allocation</h4> <p>The method of generating the randomisation sequence was not described or was not clear in eight of these studies; 12 studies were assessed to be at low risk of bias for sequence generation. In these studies the sequence was determined by random number tables, by computer, or by an external randomisation service (<a href="./references#CD004352-bbs2-0002" title="BardenTP . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1990. ">Barden 1980</a>; <a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0009" title="HobelCJ . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Hobel 1980</a>; <a href="./references#CD004352-bbs2-0012" title="KovacsVL , MeszarosG , PalA , SzaszK . Tocolysis with clenbuterol tablets. Zentralblatt fur Gynakologie1987;109:1368‐73. ">Kovacs 1987</a>; <a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>; <a href="./references#CD004352-bbs2-0017" title="MarionaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Mariona 1980</a>; <a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a>; <a href="./references#CD004352-bbs2-0022" title="ScommegnaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Scommegna 1980</a>; <a href="./references#CD004352-bbs2-0024" title="SpellacyWN , CruzAC , BuhiWC , BirkSA . The acute effects of ritodrine infusion on maternal metabolism: measurements of levels of glucose, insulin, glucagon, triglycerides, cholesterol, placental lactogen, and chorionic gonadotropin. American Journal of Obstetrics and Gynecology1978;131:637‐42. ">Spellacy 1978</a>; <a href="./references#CD004352-bbs2-0025" title="SpellacyWN , CruzAC , BirkSA , BuhiWC . Treatment of premature labour with ritodrine: a randomized controlled study. Obstetrics &amp; Gynecology1979;54:220‐3. ">Spellacy 1979</a>; <a href="./references#CD004352-bbs2-0027" title="Tohoku Research Group for Prevention of Preterm Birth. Effectiveness of ritodrine hydrochloride for tocolysis in threatened preterm delivery ‐ double blinded trial. Igaku no Ayumi1984;131(4):270‐8. ">Tohoku 1984</a>). </p> <p>Seven of the included trials reported adequate concealment of allocation (<a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0010" title="HolleboomCAG , MerkusJMWM , vanElferenLWM , KeirseMJNC . Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. British Journal of Obstetrics and Gynaecology1996;103:695‐701. ">Holleboom 1996</a>; <a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>; <a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>; <a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a>; <a href="./references#CD004352-bbs2-0027" title="Tohoku Research Group for Prevention of Preterm Birth. Effectiveness of ritodrine hydrochloride for tocolysis in threatened preterm delivery ‐ double blinded trial. Igaku no Ayumi1984;131(4):270‐8. ">Tohoku 1984</a>). The method of concealment of allocation was unclear in the remaining trials (<a href="./references#CD004352-bbs2-0001" title="AdamGS . Isoxuprine and premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1966;6:294‐8. ">Adam 1966</a>; <a href="./references#CD004352-bbs2-0002" title="BardenTP . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1990. ">Barden 1980</a>; <a href="./references#CD004352-bbs2-0004" title="CottonDB , StrassnerHT , HillLM , SchifrinBS , PaulRH . Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine1984;29:92‐7. ">Cotton 1984</a>; <a href="./references#CD004352-bbs2-0006" title="CrepinG , DelcroixM , ParmentierD , AdamMH , RenonD , GeorgesD . Use of a slow‐release form of salbutamol in the treatment of threatened premature labor. A comparative study of 52 randomized cases compared with the immediate release form [Utilisation d'une forme 'retard' de Salbutamol dans le traitement des menaces d'accouchement premature. Etude comparative de 52 cas randomises avec la forme a liberation immediate]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18(8):1063‐7. ">Crepin 1989</a>; <a href="./references#CD004352-bbs2-0007" title="EssedGGM , EskesTKAB , JongsmaHW . A randomized trial of two beta‐mimetic drugs for the treatment of threatening early labor. Clinical results in a prospective comparative study with ritodrine and fenoterol. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:341‐8. ">Essed 1978</a>; <a href="./references#CD004352-bbs2-0008" title="GummerusM . Tocolysis with hexoprenalin and salbutamol in clinical comparison. Geburtshilfe und Frauenheilkunde1983;43:151‐5. ">Gummerus 1983</a>; <a href="./references#CD004352-bbs2-0009" title="HobelCJ . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Hobel 1980</a>; <a href="./references#CD004352-bbs2-0012" title="KovacsVL , MeszarosG , PalA , SzaszK . Tocolysis with clenbuterol tablets. Zentralblatt fur Gynakologie1987;109:1368‐73. ">Kovacs 1987</a>; <a href="./references#CD004352-bbs2-0013" title="KullanderS , SvanbergL . On resorption and the effects of vaginally administered terbutaline in women with premature labor. Acta Obstetricia et Gynecologica Scandinavica1985;64:613‐6. ">Kullander 1985</a>; <a href="./references#CD004352-bbs2-0014" title="HesseldahlH . A Danish multicenter study on Ritodrine r in the treatment of pre‐term labour. Danish Medical Bulletin1979;26:116‐8. KristoffersenK , HansenMK . The condition of the foetus and infant in cases treated with Ritodrine r. Danish Medical Bulletin1979;26:121‐2. LarsenJF , HansenMK , HesseldahlH , KristoffersenK , LarsenPK , OslerM , et al. Ritodrine in the treatment of preterm labour ‐ a clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. British Journal of Obstetrics and Gynaecology1980;87:949‐57. OslerM . Side effects and metabolic changes during treatment with betamimetics (Ritodrine r). Danish Medical Bulletin1979;26:119‐20. ">Larsen 1980</a>; <a href="./references#CD004352-bbs2-0016" title="LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ . Comparison of the cardiovascular effects of hexoprenaline and ritodrine in the treatment of preterm labor. Proceedings of 3rd Annual Meeting of Society of Perinatal Obstetricians; 1983 January; San Antonio, Texas, USA. 1983:13. LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ , et al. Comparison of hexoprenaline and ritodrine in the treatment of preterm labor: United States multicenter study. Proceedings of 11th European Congress of Perinatal Medicine; 1988 April 10‐13; Rome, Italy. 1988. ">Lipshitz 1988</a>; <a href="./references#CD004352-bbs2-0017" title="MarionaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Mariona 1980</a>; <a href="./references#CD004352-bbs2-0019" title="PasargiklianR , MontiG , BertulessiC . Clenbuterol in the treatment of premature labor. Minerva Ginecologica1983;35:423‐9. ">Pasargiklian 1983</a>; <a href="./references#CD004352-bbs2-0020" title="PenneyLL , DaniellWC . Estimation of success in treatment of premature labor: applicability of prolongation index in a double‐blind, controlled, randomized trial. American Journal of Obstetrics and Gynecology1980;138:345‐6. ">Penney 1980</a>; <a href="./references#CD004352-bbs2-0021" title="PhilipsenT , EriksenPS , LynggardF . Pulmonary edema following ritodrine‐saline infusion in premature labor. Obstetrics &amp; Gynecology1981;58:304‐8. ">Philipsen 1981</a>; <a href="./references#CD004352-bbs2-0022" title="ScommegnaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Scommegna 1980</a>; <a href="./references#CD004352-bbs2-0023" title="SpellacyWN . The effects of ritodrine on maternal metabolism. Gynecologic Investigation1974;5:42. ">Spellacy 1974</a>; <a href="./references#CD004352-bbs2-0024" title="SpellacyWN , CruzAC , BuhiWC , BirkSA . The acute effects of ritodrine infusion on maternal metabolism: measurements of levels of glucose, insulin, glucagon, triglycerides, cholesterol, placental lactogen, and chorionic gonadotropin. American Journal of Obstetrics and Gynecology1978;131:637‐42. ">Spellacy 1978</a>; <a href="./references#CD004352-bbs2-0025" title="SpellacyWN , CruzAC , BirkSA , BuhiWC . Treatment of premature labour with ritodrine: a randomized controlled study. Obstetrics &amp; Gynecology1979;54:220‐3. ">Spellacy 1979</a>; <a href="./references#CD004352-bbs2-0026" title="ThoulonJM , DelecourM , KellerB , LeratMF , PuechF , SchweitzerR , et al. Multicenter comparison between two doses of IV ritodrine infusion in the management of premature labors. Proceedings of 8th European Congress of Perinatal Medicine; 1982 September 7‐10; Brussels, Belgium. 1982:153. ">Thoulon 1982</a>; <a href="./references#CD004352-bbs2-0028" title="BradenG , VonOeyenP , GermainM , WatsonD , HaagB . Ritodrine‐ and terbutaline‐induced hypokalemia in preterm labor: mechanisms and consequences. Kidney International1997;51:1867‐75. VonOeyenP , BradenG , SmithM , GarbJ , LiucciL . A randomized study comparing ritodrine and terbutaline for the treatment of preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:186. ">Von Oeyen 1990</a>). All these trials were conducted before 1990, the majority more than 25 years ago. More information on allocation of concealment could not be obtained from the authors. We decided to include these papers. </p> </section> <section id="CD004352-sec-0069"> <h4 class="title">Blinding</h4> <p>Method of blinding (double‐blind and single‐bind) was reported in 15 trials (<a href="./references#CD004352-bbs2-0001" title="AdamGS . Isoxuprine and premature labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1966;6:294‐8. ">Adam 1966</a>; <a href="./references#CD004352-bbs2-0002" title="BardenTP . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1990. ">Barden 1980</a>; <a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0006" title="CrepinG , DelcroixM , ParmentierD , AdamMH , RenonD , GeorgesD . Use of a slow‐release form of salbutamol in the treatment of threatened premature labor. A comparative study of 52 randomized cases compared with the immediate release form [Utilisation d'une forme 'retard' de Salbutamol dans le traitement des menaces d'accouchement premature. Etude comparative de 52 cas randomises avec la forme a liberation immediate]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18(8):1063‐7. ">Crepin 1989</a>; <a href="./references#CD004352-bbs2-0009" title="HobelCJ . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Hobel 1980</a>; <a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>; <a href="./references#CD004352-bbs2-0017" title="MarionaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Mariona 1980</a>; <a href="./references#CD004352-bbs2-0020" title="PenneyLL , DaniellWC . Estimation of success in treatment of premature labor: applicability of prolongation index in a double‐blind, controlled, randomized trial. American Journal of Obstetrics and Gynecology1980;138:345‐6. ">Penney 1980</a>; <a href="./references#CD004352-bbs2-0021" title="PhilipsenT , EriksenPS , LynggardF . Pulmonary edema following ritodrine‐saline infusion in premature labor. Obstetrics &amp; Gynecology1981;58:304‐8. ">Philipsen 1981</a>; <a href="./references#CD004352-bbs2-0022" title="ScommegnaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Scommegna 1980</a>; <a href="./references#CD004352-bbs2-0023" title="SpellacyWN . The effects of ritodrine on maternal metabolism. Gynecologic Investigation1974;5:42. ">Spellacy 1974</a>; <a href="./references#CD004352-bbs2-0024" title="SpellacyWN , CruzAC , BuhiWC , BirkSA . The acute effects of ritodrine infusion on maternal metabolism: measurements of levels of glucose, insulin, glucagon, triglycerides, cholesterol, placental lactogen, and chorionic gonadotropin. American Journal of Obstetrics and Gynecology1978;131:637‐42. ">Spellacy 1978</a>; <a href="./references#CD004352-bbs2-0025" title="SpellacyWN , CruzAC , BirkSA , BuhiWC . Treatment of premature labour with ritodrine: a randomized controlled study. Obstetrics &amp; Gynecology1979;54:220‐3. ">Spellacy 1979</a>; <a href="./references#CD004352-bbs2-0027" title="Tohoku Research Group for Prevention of Preterm Birth. Effectiveness of ritodrine hydrochloride for tocolysis in threatened preterm delivery ‐ double blinded trial. Igaku no Ayumi1984;131(4):270‐8. ">Tohoku 1984</a>), In some trials women were described as blinded, but it is unlikely that staff would have been unaware of treatment allocation as regimens in different arms of trials were not identical; other trials did not discuss blinding at all. </p> </section> <section id="CD004352-sec-0070"> <h4 class="title">Incomplete outcome data</h4> <p>In this review, we have attempted to conduct an intention‐to‐treat analysis for all outcomes. All or most participants in 15 trials completed the study and most participants were accounted for in the analysis (<a href="./references#CD004352-bbs2-0002" title="BardenTP . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1990. ">Barden 1980</a>; <a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0004" title="CottonDB , StrassnerHT , HillLM , SchifrinBS , PaulRH . Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine1984;29:92‐7. ">Cotton 1984</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0009" title="HobelCJ . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Hobel 1980</a>; <a href="./references#CD004352-bbs2-0010" title="HolleboomCAG , MerkusJMWM , vanElferenLWM , KeirseMJNC . Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. British Journal of Obstetrics and Gynaecology1996;103:695‐701. ">Holleboom 1996</a>; <a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>; <a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>; <a href="./references#CD004352-bbs2-0017" title="MarionaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Mariona 1980</a>; <a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a>; <a href="./references#CD004352-bbs2-0019" title="PasargiklianR , MontiG , BertulessiC . Clenbuterol in the treatment of premature labor. Minerva Ginecologica1983;35:423‐9. ">Pasargiklian 1983</a>; <a href="./references#CD004352-bbs2-0021" title="PhilipsenT , EriksenPS , LynggardF . Pulmonary edema following ritodrine‐saline infusion in premature labor. Obstetrics &amp; Gynecology1981;58:304‐8. ">Philipsen 1981</a>; <a href="./references#CD004352-bbs2-0022" title="ScommegnaA . Randomised trial of ritodrine vs placebo in threatened preterm delivery. Personal communication1980. ">Scommegna 1980</a>; <a href="./references#CD004352-bbs2-0025" title="SpellacyWN , CruzAC , BirkSA , BuhiWC . Treatment of premature labour with ritodrine: a randomized controlled study. Obstetrics &amp; Gynecology1979;54:220‐3. ">Spellacy 1979</a>; <a href="./references#CD004352-bbs2-0027" title="Tohoku Research Group for Prevention of Preterm Birth. Effectiveness of ritodrine hydrochloride for tocolysis in threatened preterm delivery ‐ double blinded trial. Igaku no Ayumi1984;131(4):270‐8. ">Tohoku 1984</a>). In two trials attrition may have related to treatment group and these trials were judged to be at high risk of bias for this domain (<a href="./references#CD004352-bbs2-0006" title="CrepinG , DelcroixM , ParmentierD , AdamMH , RenonD , GeorgesD . Use of a slow‐release form of salbutamol in the treatment of threatened premature labor. A comparative study of 52 randomized cases compared with the immediate release form [Utilisation d'une forme 'retard' de Salbutamol dans le traitement des menaces d'accouchement premature. Etude comparative de 52 cas randomises avec la forme a liberation immediate]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18(8):1063‐7. ">Crepin 1989</a>; <a href="./references#CD004352-bbs2-0007" title="EssedGGM , EskesTKAB , JongsmaHW . A randomized trial of two beta‐mimetic drugs for the treatment of threatening early labor. Clinical results in a prospective comparative study with ritodrine and fenoterol. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:341‐8. ">Essed 1978</a>). In the remaining trials loss to follow‐up was not mentioned or not clear. </p> </section> <section id="CD004352-sec-0071"> <h4 class="title">Selective reporting</h4> <p>Assessing selective reporting bias without access to trial protocols is difficult, and most studies were assessed as unclear. In the study by <a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a>, outcomes for infants were only reported for those born after 37 weeks' gestation; data for infant outcomes were therefore at high risk of bias and have not been included in the data and analysis tables in the review. </p> </section> <section id="CD004352-sec-0072"> <h4 class="title">Other potential sources of bias</h4> <p>In two studies there appeared to be baseline differences between groups (<a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0007" title="EssedGGM , EskesTKAB , JongsmaHW . A randomized trial of two beta‐mimetic drugs for the treatment of threatening early labor. Clinical results in a prospective comparative study with ritodrine and fenoterol. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:341‐8. ">Essed 1978</a>), and in one study there was considerable deviation from the protocol (<a href="./references#CD004352-bbs2-0010" title="HolleboomCAG , MerkusJMWM , vanElferenLWM , KeirseMJNC . Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. British Journal of Obstetrics and Gynaecology1996;103:695‐701. ">Holleboom 1996</a>). </p> </section> </section> <section id="CD004352-sec-0073"> <h3 class="title" id="CD004352-sec-0073">Effects of interventions</h3> <section id="CD004352-sec-0074"> <h4 class="title">1. Betamimetics compared with placebo (comparison 1)</h4> <p>Twelve trials compared betamimetics with placebo; trials included a total of 732 women in placebo groups and 635 women in betamimetics group. One trial (<a href="./references#CD004352-bbs2-0014" title="HesseldahlH . A Danish multicenter study on Ritodrine r in the treatment of pre‐term labour. Danish Medical Bulletin1979;26:116‐8. KristoffersenK , HansenMK . The condition of the foetus and infant in cases treated with Ritodrine r. Danish Medical Bulletin1979;26:121‐2. LarsenJF , HansenMK , HesseldahlH , KristoffersenK , LarsenPK , OslerM , et al. Ritodrine in the treatment of preterm labour ‐ a clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. British Journal of Obstetrics and Gynaecology1980;87:949‐57. OslerM . Side effects and metabolic changes during treatment with betamimetics (Ritodrine r). Danish Medical Bulletin1979;26:119‐20. ">Larsen 1980</a>) randomised the participants into four groups: long ritodrine infusion group, short ritodrine infusion group, intramuscular group and placebo. Data from all women on ritodrine regimens (three groups) were pooled together to compare with placebo‐treated women. </p> <section id="CD004352-sec-0075"> <h5 class="title">Primary outcomes</h5> <section id="CD004352-sec-0076"> <h6 class="title">Birth within 48 hours of treatment</h6> <p>The use of betamimetics significantly decreased the number of women giving birth within 48 hours (average risk ratio (RR) 0.68; 95% confidence interval (CI) 0.53 to 0.88, 10 trials, 1209 women) (<a href="./references#CD004352-fig-0005" title="">Analysis 1.1</a>). There was moderate heterogeneity for this outcome (I<sup>2</sup> = 32%) and we used a random‐effects model. The effect of betamimetics on reduction of birth within 48 hours was not changed after sensitivity analysis, retaining only studies with adequate allocation concealment (<a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>; <a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>) (average RR 0.55; 95% CI 0.38 to 0.80) (data not shown). There was no obvious funnel plot asymmetry for this outcome (<a href="#CD004352-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD004352-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 All betamimetics versus placebo, outcome: 1.1 Birth within 48 hours of treatment." data-id="CD004352-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 All betamimetics versus placebo, outcome: 1.1 Birth within 48 hours of treatment. </p> </div> </div> </div> </section> <section id="CD004352-sec-0077"> <h6 class="title">Perinatal death (up to seven days) and serious neonatal morbidity</h6> <p>Betamimetics were not shown to reduce perinatal deaths (RR 0.84; 95% CI 0.46 to 1.55, 11 trials, 1332 infants) (<a href="./references#CD004352-fig-0006" title="">Analysis 1.2</a>), respiratory distress syndrome (RR 0.87; 95% CI 0.71 to 1.08, eight trials, 1239 infants) (<a href="./references#CD004352-fig-0007" title="">Analysis 1.3</a>), or cerebral palsy (RR 0.19; 95% CI 0.02 to 1.63, one trial, 246 infants) (<a href="./references#CD004352-fig-0008" title="">Analysis 1.4</a>), Differences between groups remained non‐significant when we carried out sensitivity analysis retaining only those studies at low risk of bias for allocation concealment (data not shown).Visual assessment suggested no obvious funnel plot asymmetry for perinatal death (<a href="#CD004352-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD004352-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 All betamimetics versus placebo, outcome: 1.2 Perinatal death (7 days)." data-id="CD004352-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 All betamimetics versus placebo, outcome: 1.2 Perinatal death (7 days). </p> </div> </div> </div> </section> <section id="CD004352-sec-0078"> <h6 class="title">Neonatal length of hospital stay</h6> <p>Only one trial reported the mean neonatal length of hospital stay (<a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>) with the total length of hospital stay being 24.5 days in the ritodrine group and 24.8 days in the placebo group. The mean neonatal length of intensive care stay was 14.3 days in the ritodrine group and 12.4 days in the placebo group. (Standard deviations were not provided in the trial report and data for these outcomes are not shown in data and analyses tables.) </p> </section> </section> <section id="CD004352-sec-0079"> <h5 class="title">Maternal secondary outcomes</h5> <p>Betamimetics decreased the frequency of birth within seven days (average RR 0.80; 95% CI 0.65 to 0.98, five trials, 911 women) (<a href="./references#CD004352-fig-0009" title="">Analysis 1.5</a>), but did not significantly reduce the risk of delivering prior to 37 weeks' gestation (RR 0.95; 95% CI 0.88 to 1.03, 10 trials, 1212 women) (<a href="./references#CD004352-fig-0010" title="">Analysis 1.6</a>). </p> <p>No subgroup data based on birth before 28 and before 34 completed weeks were reported because most participants were 32 weeks' gestation or more. </p> <p>No maternal deaths were reported in two trials that explicitly reported this (<a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0014" title="HesseldahlH . A Danish multicenter study on Ritodrine r in the treatment of pre‐term labour. Danish Medical Bulletin1979;26:116‐8. KristoffersenK , HansenMK . The condition of the foetus and infant in cases treated with Ritodrine r. Danish Medical Bulletin1979;26:121‐2. LarsenJF , HansenMK , HesseldahlH , KristoffersenK , LarsenPK , OslerM , et al. Ritodrine in the treatment of preterm labour ‐ a clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. British Journal of Obstetrics and Gynaecology1980;87:949‐57. OslerM . Side effects and metabolic changes during treatment with betamimetics (Ritodrine r). Danish Medical Bulletin1979;26:119‐20. ">Larsen 1980</a>). Other serious maternal outcomes, for example, cardiac arrest, respiratory arrest and admission to intensive care unit, were not reported in any trial. Maternal pulmonary oedema was reported in three trials; only one case was identified (<a href="./references#CD004352-bbs2-0004" title="CottonDB , StrassnerHT , HillLM , SchifrinBS , PaulRH . Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. Journal of Reproductive Medicine1984;29:92‐7. ">Cotton 1984</a>; <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>; <a href="./references#CD004352-bbs2-0015" title="LevenoKJ , GuzickDS , HankinsGDV , KleinVR , YoungDC , WilliamsML . Single‐centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet1986;1:1293‐6. LevenoKJ , KleinVR , GuzickDS , WilliamsML , YoungDC , HankinsG . A single‐center randomized, controlled trial of ritodrine hydrochloride. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 January 30‐February 1; San Antonio, Texas, USA. 1986:155. ">Leveno 1986</a>) (RR 3.03; 95% CI 0.12 to 74.23) (<a href="./references#CD004352-fig-0012" title="">Analysis 1.8</a>). There were no significant differences between groups for maternal cardiac arrhythmias (RR 3.54; 95% CI 0.74 to 16.92, one trial, 708 women) (<a href="./references#CD004352-fig-0013" title="">Analysis 1.9</a>); myocardial ischaemia (RR 12.53; 95% CI 0.72 to 216.91, one trial, 106 women) (<a href="./references#CD004352-fig-0014" title="">Analysis 1.10</a>), or maternal hypotension (average RR 1.56; 95% 0.12 to 20.86, two trials, 136 women) (<a href="./references#CD004352-fig-0015" title="">Analysis 1.11</a>). </p> <p>The frequency of other maternal adverse effects varied in different trials but overall, were significantly increased with betamimetics compared to placebo: cessation of treatment due to adverse drug reaction (RR 11.38; 95% CI 5.21 to 24.86, five trials, 1081 women) (<a href="./references#CD004352-fig-0016" title="">Analysis 1.12</a>); chest pain (RR 11.29; 95% CI 3.81 to 33.46, two trials, 814 women) (<a href="./references#CD004352-fig-0019" title="">Analysis 1.15</a>); dyspnoea (RR 3.86; 95% CI 2.21 to 6.77, two trials, 814 women) (<a href="./references#CD004352-fig-0020" title="">Analysis 1.16</a>); palpitation (RR 9.91; 95% CI 6.46 to 15.20, five trials, 1089 women) (<a href="./references#CD004352-fig-0017" title="">Analysis 1.13</a>); tremor (RR 10.74; 95% CI 6.20 to 18.59, one trial 708 women) (<a href="./references#CD004352-fig-0021" title="">Analysis 1.17</a>); headaches (RR 4.07; 95% CI 2.60 to 6.35, three trials, 936 women) (<a href="./references#CD004352-fig-0026" title="">Analysis 1.22</a>); hypokalaemia (RR 6.07; 95% CI 4.00 to 9.20, one trial, 708 women) (<a href="./references#CD004352-fig-0023" title="">Analysis 1.19</a>); hyperglycaemia (RR 2.90; 95% CI 2.05 to 4.09, one trial, 708 women) (<a href="./references#CD004352-fig-0022" title="">Analysis 1.18</a>); nausea or vomiting (RR 1.76; 95% CI 1.29 to 2.42, three trials, 932 women) (<a href="./references#CD004352-fig-0024" title="">Analysis 1.20</a>); and nasal stuffiness (RR 2.90; 95% CI 1.64 to 5.12, one trial, 708 women) (<a href="./references#CD004352-fig-0025" title="">Analysis 1.21</a>). Two trials reported tachycardia; in one trial there was a significant difference between groups, while in the second trial, similar numbers of women in both groups reported this side effect and we have not pooled results for this outcome (<a href="./references#CD004352-fig-0018" title="">Analysis 1.14</a>). </p> </section> <section id="CD004352-sec-0080"> <h5 class="title">Neonatal secondary outcomes</h5> <p>There were no statistically significant differences between groups for neonatal death (average RR 0.90; 95% CI 0.27 to 3.00, six trials, 1174 infants) (<a href="./references#CD004352-fig-0027" title="">Analysis 1.23</a>), infant death (RR 0.51; 95% CI 0.05 to 5.64, one trial, 750 women) (<a href="./references#CD004352-fig-0028" title="">Analysis 1.24</a>) and necrotising enterocolitis (RR 0.42; 95% CI 0.06 to 2.78, two trials, 149 infants) (<a href="./references#CD004352-fig-0029" title="">Analysis 1.25</a>). Significant heterogeneity was identified for two outcomes: sepsis and fetal hypoglycaemia, and results were not pooled for these outcomes (<a href="./references#CD004352-fig-0030" title="">Analysis 1.26</a>; <a href="./references#CD004352-fig-0031" title="">Analysis 1.27</a>).Fetal tachycardia associated with betamimetics was significantly increased compared with placebo in one trial with data for 30 infants (RR 2.40; 95% CI 1.12 to 5.13) (<a href="./references#CD004352-bbs2-0011" title="IngemarssonI . Effect of terbutaline on premature labor. A double‐blind placebo‐controlled study. American Journal of Obstetrics and Gynecology1976;125:520‐4. ">Ingemarsson 1976</a>) (<a href="./references#CD004352-fig-0032" title="">Analysis 1.28</a>). </p> <p>No data on chronic lung disease, bronchopulmonary dysplasia, severe neuroradiological abnormality, and retinopathy of prematurity were reported. Only one trial reported abnormal long‐term neurodevelopmental status after follow‐up of 246 infants at 18 months (<a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>). There was no significant difference between groups on the Bayley Psychomotor Development Index (mean difference (MD) 1.30; 95% CI ‐2.74 to 5.34) (<a href="./references#CD004352-fig-0033" title="">Analysis 1.29</a>). The average score on the Bayley Mental Developmental Index was slightly higher in the ritodrine group (MD 5.20; 95% CI 0.56 to 9.84) (<a href="./references#CD004352-fig-0034" title="">Analysis 1.30</a>). </p> </section> </section> <section id="CD004352-sec-0081"> <h4 class="title">2. Other betamimetics compared with ritodrine</h4> </section> <section id="CD004352-sec-0082"> <h4 class="title">Terbutaline compared with ritodrine (comparison 2)</h4> <p>There were only two trials in this group involving 183 women: 90 in the terbutaline group and 93 in the ritodrine group (<a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>; <a href="./references#CD004352-bbs2-0028" title="BradenG , VonOeyenP , GermainM , WatsonD , HaagB . Ritodrine‐ and terbutaline‐induced hypokalemia in preterm labor: mechanisms and consequences. Kidney International1997;51:1867‐75. VonOeyenP , BradenG , SmithM , GarbJ , LiucciL . A randomized study comparing ritodrine and terbutaline for the treatment of preterm labor. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:186. ">Von Oeyen 1990</a>). Only 19 outcomes were reported. </p> <section id="CD004352-sec-0083"> <h5 class="title">Primary outcomes</h5> <section id="CD004352-sec-0084"> <h6 class="title">Birth within 48 hours of treatment</h6> <p>There was no significant difference between terbutaline and ritodrine for the number of women giving birth within 48 hours in one trial with 83 women (RR 2.05; 95% confidence interval (CI) 0.77 to 5.48, one trial) (<a href="./references#CD004352-fig-0035" title="">Analysis 2.1</a>). </p> </section> <section id="CD004352-sec-0085"> <h6 class="title">Perinatal death (up to seven days) and serious neonatal morbidity</h6> <p>There were no significant differences between the two betamimetics for perinatal deaths (no deaths in one trial with 83 infants) (<a href="./references#CD004352-fig-0036" title="">Analysis 2.2</a>) or respiratory distress syndrome (RR 1.99; 95% CI 0.93 to 4.27, one trial, 101 infants) (<a href="./references#CD004352-fig-0037" title="">Analysis 2.3</a>). Cerebral palsy was not reported. </p> </section> <section id="CD004352-sec-0086"> <h6 class="title">Neonatal length of hospital stay</h6> <p>Length of hospital stay was not reported in either trial contributing data to this comparison. </p> </section> </section> <section id="CD004352-sec-0087"> <h5 class="title">Secondary outcomes</h5> <p>Most of our secondary maternal and infant outcomes were not reported.</p> <p>Hyperglycaemia was statistically significantly increased in the terbutaline group (RR 1.78; 95% CI 1.05 to 3.03) (<a href="./references#CD004352-fig-0044" title="">Analysis 2.10</a>). However, this outcome was reported in one trial with 100 women only (<a href="./references#CD004352-bbs2-0003" title="CaritisSN , ToigG , HeddingerLA , AshmeadG . A double‐blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American Journal of Obstetrics and Gynecology1984;150:7‐14. ">Caritis 1984</a>). Other maternal and neonatal outcomes (measured in only one trial) were not statistically significantly different between the two groups: birth within seven days (RR 0.80; 95% CI 0.57 to 1.10) (<a href="./references#CD004352-fig-0038" title="">Analysis 2.4</a>); birth before 28 completed weeks (RR 2.08; 95% CI 0.55 to 7.87) (<a href="./references#CD004352-fig-0039" title="">Analysis 2.5</a>); or cessation of treatment due to adverse drug reactions (RR 0.83; 95% CI 0.24 to 2.92) (<a href="./references#CD004352-fig-0040" title="">Analysis 2.6</a>). Both trials reported chest pain, shortness of breath and hypotension; there were no significant differences between groups for any of these outcomes (RR 1.11; 95% CI 0.55 to 2.25; RR 0.83; 95% CI 0.41 to 1.67, and RR 1.00; 95% CI 0.67 to 1.49 respectively). Dyspnoea, arrhythmia, tachycardia, palpitation, and headache were reported in only one trial and there were no clear differences between terbutaline and ritodrine for these side effects. </p> </section> </section> <section id="CD004352-sec-0088"> <h4 class="title">Fenoterol compared with ritodrine (comparison 3)</h4> <p>There was only one trial in this group, involving 48 women in each group (<a href="./references#CD004352-bbs2-0007" title="EssedGGM , EskesTKAB , JongsmaHW . A randomized trial of two beta‐mimetic drugs for the treatment of threatening early labor. Clinical results in a prospective comparative study with ritodrine and fenoterol. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1978;8:341‐8. ">Essed 1978</a>). Only six outcomes were reported. </p> <section id="CD004352-sec-0089"> <h5 class="title">Maternal and neonatal outcomes</h5> <p>Neonatal death was statistically significantly decreased in the fenoterol group (RR 0.13; 95% CI 0.02 to 0.96) (<a href="./references#CD004352-fig-0059" title="">Analysis 3.6</a>). However, the sample size was small and the methodological quality of the single study reporting this outcome was poor. There were no statistically significant differences between the groups for other maternal and neonatal outcomes reported: perinatal death; respiratory distress syndrome; tachycardia; fetal bradycardia; and hypoglycaemia. </p> </section> </section> <section id="CD004352-sec-0090"> <h4 class="title">Ritodrine loading dose with conventional incremental dose (comparison 4)</h4> <p>There was only one trial in this group involving 203 women: 101 in the ritodrine loading dose group and 102 in the incremental dose group (<a href="./references#CD004352-bbs2-0010" title="HolleboomCAG , MerkusJMWM , vanElferenLWM , KeirseMJNC . Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. British Journal of Obstetrics and Gynaecology1996;103:695‐701. ">Holleboom 1996</a>). Only 12 outcomes were reported. </p> <p>There were no statistically significant differences between the groups for maternal and neonatal outcomes: birth within 48 hours; birth before 34 completed weeks; birth before 37 completed weeks; respiratory distress syndrome; any maternal adverse effects; tachycardia; nausea or vomiting; palpitation; headache; neonatal death; periventricular haemorrhage grade three to four; and sepsis. </p> </section> <section id="CD004352-sec-0091"> <h4 class="title">Hexoprenaline compared with ritodrine (comparison 5)</h4> <p>There was only one trial in this group involving 466 women: 314 in the hexoprenaline group and 152 in the ritodrine group (<a href="./references#CD004352-bbs2-0016" title="LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ . Comparison of the cardiovascular effects of hexoprenaline and ritodrine in the treatment of preterm labor. Proceedings of 3rd Annual Meeting of Society of Perinatal Obstetricians; 1983 January; San Antonio, Texas, USA. 1983:13. LipshitzJ , DeppR , HauthJ , HayashiR , MorrisonJ , SchneiderJ , et al. Comparison of hexoprenaline and ritodrine in the treatment of preterm labor: United States multicenter study. Proceedings of 11th European Congress of Perinatal Medicine; 1988 April 10‐13; Rome, Italy. 1988. ">Lipshitz 1988</a>). Only six outcomes were reported. </p> <p>Maternal and neonatal adverse effects were statistically significantly decreased in the hexoprenaline group: cessation of treatment due to adverse reaction (RR 0.28; 95% CI 0.08 to 0.93) (<a href="./references#CD004352-fig-0072" title="">Analysis 5.1</a>); any maternal adverse effects (RR 0.83; 95% CI 0.76 to 0.91) (<a href="./references#CD004352-fig-0073" title="">Analysis 5.2</a>); nausea or vomiting (RR 0.63; 95% CI 0.45 to 0.89) (<a href="./references#CD004352-fig-0076" title="">Analysis 5.5</a>); palpitation (RR 0.75; 95% CI 0.60 to 0.94) (<a href="./references#CD004352-fig-0074" title="">Analysis 5.3</a>); hypotension (RR 0.77; 95% CI 0.61 to 0.96) (<a href="./references#CD004352-fig-0075" title="">Analysis 5.4</a>); increased fetal heart rate (RR 0.74; 95% CI 0.56 to 0.98) (<a href="./references#CD004352-fig-0077" title="">Analysis 5.6</a>). However, the quality of this trial was poor (abstract only). </p> </section> <section id="CD004352-sec-0092"> <h4 class="title">Hexoprenaline compared with salbutamol (comparison 6)</h4> <p>There was only one trial in this group involving 140 women: 70 in the hexoprenaline group and 70 in the salbutamol group (<a href="./references#CD004352-bbs2-0008" title="GummerusM . Tocolysis with hexoprenalin and salbutamol in clinical comparison. Geburtshilfe und Frauenheilkunde1983;43:151‐5. ">Gummerus 1983</a>). Only six outcomes were reported. </p> <p>Maternal adverse effects were statistically significantly decreased in the hexoprenaline group: any maternal adverse effects (RR 0.38; 95% CI 0.18 to 0.80) ( <a href="./references#CD004352-fig-0080" title="">Analysis 6.3</a>) and tachycardia (RR 0.11; 95% CI 0.01 to 0.85) (<a href="./references#CD004352-fig-0081" title="">Analysis 6.4</a>). However, the methodological quality of this trial was poor. There were no statistically significant differences between the groups for respiratory distress syndrome, cessation of treatment due to adverse reactions, nausea or vomiting, headache, and tremor. </p> <p>Subgroup analysis based on adjunctive steroid treatment was not done because of the low incidence of corticosteroid usage in all trials. </p> </section> <section id="CD004352-sec-0093"> <h4 class="title">Terbutaline compared with salbutamol (comparison 7)</h4> <p>Only one trial with 200 women contributed data to this comparison (<a href="./references#CD004352-bbs2-0018" title="MotazedianS , GhaffarpasandF , MojtahediK , AsadiN . Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Annals of Saudi Medicine2010;30(5):370‐5. ">Motazedian 2010</a>) and few of our primary and secondary outcomes were reported. </p> <p>There was no significant difference between women receiving terbutaline and salbutamol for birth within 48 hours (RR 0.63; 95% CI 0.21 to 1.84). </p> <p>Side effects were more likely in the salbutamol group. Women in the terbutaline group were at reduced risk of side effects overall (RR 0.54; 95% CI 0.42 to 0.70) (<a href="./references#CD004352-fig-0086" title="">Analysis 7.2</a>); and of tachycardia (RR 0.48; 95% CI 0.30 to 0.75) (<a href="./references#CD004352-fig-0087" title="">Analysis 7.3</a>); anxiety (RR 0.48; 95% CI 0.28 to 0.84) (<a href="./references#CD004352-fig-0090" title="">Analysis 7.6</a>); and chills (RR 0.48; 95% CI 0.34 to 0.69) (<a href="./references#CD004352-fig-0091" title="">Analysis 7.7</a>). There were no statistically significant differences between groups for dyspnoea (RR 0.42; 95% CI 0.15 to 1.14) (<a href="./references#CD004352-fig-0088" title="">Analysis 7.4</a>), nausea (RR 0.66; 95% CI 0.39 to 1.09) (<a href="./references#CD004352-fig-0089" title="">Analysis 7.5</a>), or oedema (RR 0.75; 95% CI 0.17 to 3.27) (<a href="./references#CD004352-fig-0092" title="">Analysis 7.8</a>). </p> <p>The length of maternal hospital stay was reduced in the terbutaline group (MD ‐0.80 days; 95% CI ‐1.19 to ‐0.41) (<a href="./references#CD004352-fig-0093" title="">Analysis 7.9</a>). </p> <p>Women who delivered during the treatment period, whose contractions did not cease within 48 hours, or who developed complications were not included in analysis for pregnancy outcomes or complications (44/200 – 22%) data for these outcomes have not been included in the review because of high risk of bias. </p> </section> <section id="CD004352-sec-0094"> <h4 class="title">Comparison 8: Slow release salbutamol compared with normal release salbutamol</h4> <p>A single trial with data for 56 women was included in this comparison (<a href="./references#CD004352-bbs2-0006" title="CrepinG , DelcroixM , ParmentierD , AdamMH , RenonD , GeorgesD . Use of a slow‐release form of salbutamol in the treatment of threatened premature labor. A comparative study of 52 randomized cases compared with the immediate release form [Utilisation d'une forme 'retard' de Salbutamol dans le traitement des menaces d'accouchement premature. Etude comparative de 52 cas randomises avec la forme a liberation immediate]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18(8):1063‐7. ">Crepin 1989</a>). None of our primary outcomes were reported. </p> <p>For maternal secondary outcomes, there was no difference between the two types of salbutamol for preterm birth (before 37 weeks) (RR 2.57; 95% CI 0.29 to 23.13) (<a href="./references#CD004352-fig-0094" title="">Analysis 8.1</a>) or caesarean birth (RR 1.29; 95% CI 0.23 to 7.07) (<a href="./references#CD004352-fig-0095" title="">Analysis 8.2</a>). None of the women in either group had severe side effects leading to discontinuation of treatment, and there was no evidence of difference in the frequency of nausea (RR 0.86; 95% CI 0.06 to 12.98) (<a href="./references#CD004352-fig-0097" title="">Analysis 8.4</a>). For infant Apgar score, no infants (in either group) were reported to have a score less than seven at five minutes. Other outcomes were not reported. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004352-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004352-sec-0095"></div> <section id="CD004352-sec-0096"> <h3 class="title" id="CD004352-sec-0096">Summary of main results</h3> <p>Betamimetics were shown to be effective in delaying birth for 48 hours and up to seven days. This is sufficient time to allow transfer of a woman to a tertiary care unit or to complete a course of antenatal corticosteroid. However, there was no evidence that this delay in the timing of birth translated into any improvements in neonatal outcomes, and the side effects for the woman are considerable. </p> <p>It may be that health gains have not been demonstrated for several reasons.</p> <p> <ol id="CD004352-list-0013"> <li> <p>Time gain in‐utero: most participants were 32 weeks' gestation or more. Therefore, increased gestational age might have little or no effect on perinatal outcomes leading to no statistical significance in the pooled estimate of important outcomes such as respiratory distress syndrome, perinatal death, neonatal death and infant death. Also, prolongation of pregnancy itself may be disadvantage to the baby. If the eligibility criteria had been restricted to lower gestation groups, and had the number of participants been greater, an effect on clinical outcomes might have been detected. </p> </li> <li> <p>Referral to higher care level: all trials in this review took place in tertiary care or University hospitals, that were likely to have neonatal intensive care facilities. If the trials had involved women who needed to be transferred to distant referral hospitals, again a difference in outcome might have been seen. </p> </li> <li> <p>Antenatal corticosteroids administration: the majority of trials were conducted before 1990, when antenatal corticosteroids were not widely used. Even in <a href="./references#CD004352-bbs2-0005" title="Anonymous . Treatment of preterm labor with the beta‐adrenergic agonist ritodrine. The Canadian Preterm Labor Investigation Group. New England Journal of Medicine1992;327:308‐12. SauveRS , collaborative. Outcomes of ritodrine exposed infants. Pediatric Research1991;29:264A. ">CPLG 1992</a>, antenatal corticosteroids were prescribed only to one third of all women in each arm. Therefore, subgroup analysis to evaluate the effect of betamimetics to allow a complete course of antenatal corticosteroids (betamimetics alone and betamimetics combined with corticosteroids) on neonatal outcomes could not be assessed. </p> </li> </ol> </p> <p>There is not enough evidence to suggest that one betamimetic agent is superior to another. </p> </section> <section id="CD004352-sec-0097"> <h3 class="title" id="CD004352-sec-0097">Agreements and disagreements with other studies or reviews</h3> <p>Betamimetics have been used for primary tocolysis and maintenance therapy for many years, and continue to be used throughout the world. However, alternative agents have been shown to be more effective in terms of pregnancy prolongation and have been associated with fewer and less severe side effects compared with betamimetics. The effects of different classes of tocolytics compared with placebo, and with each other (where different types of tocolytics have been compared directly in trials) have been set out in a series of Cochrane Reviews (<a href="./references#CD004352-bbs2-0094" title="BainE , HeatleyE , HsuK , CrowtherCA . Relaxin for preventing preterm birth. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD010073.pub2] ">Bain 2013</a>; <a href="./references#CD004352-bbs2-0098" title="CrowtherCA , HillerJE , DoyleLW . Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001060] ">Crowther 2002</a>; <a href="./references#CD004352-bbs2-0100" title="DuckittK , ThorntonS . Nitric oxide donors for the treatment of preterm labour. Cochrane Database of Systematic Reviews2002, Issue 3. [DOI: 10.1002/14651858.CD002860] ">Duckitt 2002</a>; <a href="./references#CD004352-bbs2-0107" title="KingJF , FlenadyV , PapatsonisD , DekkerG , CarbonneB . Calcium channel blockers for inhibiting preterm labour. Cochrane Database of Systematic Reviews2003, Issue 1. [DOI: 10.1002/14651858.CD002255] ">King 2003</a>; <a href="./references#CD004352-bbs2-0108" title="KingJF , FlenadyV , ColeS , ThorntonS . Cyclo‐oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD001992.pub2] ">King 2005</a>; <a href="./references#CD004352-bbs2-0113" title="PapatsonisD , FlenadyV , ColeS , LileyH . Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD004452.pub2] ">Papatsonis 2005</a>; <a href="./references#CD004352-bbs2-0117" title="SuLL , SamuelM , ChongYS . Progestational agents for treating threatened or established preterm labour. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD006770.pub2] ">Su 2010</a>), and the effects of combinations of different tocolytic drugs to treat preterm labour is the subject of a review currently in development (<a href="./references#CD004352-bbs2-0112" title="NardinJM , CarroliG , AlfirevicZ . Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006169] ">Nardin 2006</a>). A recent review, which included both network and pair‐wise meta‐analysis, incorporated evidence from 95 trials examining a range of tocolytics (betamimetics, magnesium sulphate, calcium channel blockers, COX inhibitors, oxytocin receptor antagonists, nitric oxide donors and other drugs) (<a href="./references#CD004352-bbs2-0104" title="HaasDM , CaldwellDM , KirkpatrickP , McIntoshJJ , WeltonNJ . Tocolytic therapy for preterm delivery: systematic review and network meta‐analysis. BMJ2012;345:e6226. ">Haas 2012</a>). The results of this review suggest that all types of tocolytics were better than placebo in terms of prolonging pregnancy beyond 48 hours, but that betamimetics performed less well than other types of tocolytics (e.g. COX inhibitors, and calcium channel blockers). It was not clear that any class of tocolytic was effective in reducing respiratory distress syndrome compared with placebo. The evidence regarding side effects suggested that COX inhibitors and oxytocin receptor antagonists were associated with fewer maternal side effects compared with other types of tocolytics including betamimetics. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004352-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004352-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004352-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 All betamimetics versus placebo, outcome: 1.1 Birth within 48 hours of treatment." data-id="CD004352-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 All betamimetics versus placebo, outcome: 1.1 Birth within 48 hours of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 All betamimetics versus placebo, outcome: 1.2 Perinatal death (7 days)." data-id="CD004352-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 All betamimetics versus placebo, outcome: 1.2 Perinatal death (7 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/full#CD004352-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 1 Birth within 48 hours of treatment." data-id="CD004352-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 1 Birth within 48 hours of treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 2 Perinatal death (7 days)." data-id="CD004352-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 2 Perinatal death (7 days).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 3 Respiratory distress syndrome." data-id="CD004352-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 3 Respiratory distress syndrome.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 4 Cerebral palsy." data-id="CD004352-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 4 Cerebral palsy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 5 Birth within 7 days." data-id="CD004352-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 5 Birth within 7 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 6 Birth less than 37 weeks' gestation." data-id="CD004352-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 6 Birth less than 37 weeks' gestation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 7 Maternal death." data-id="CD004352-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 7 Maternal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 8 Pulmonary oedema." data-id="CD004352-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 8 Pulmonary oedema.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 9 Cardiac arrhythmias." data-id="CD004352-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 9 Cardiac arrhythmias.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 10 Myocardial ischemia." data-id="CD004352-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 10 Myocardial ischemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 11 Hypotension." data-id="CD004352-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 11 Hypotension.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 12 Cessation of treatment due to adverse drug reaction." data-id="CD004352-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 12 Cessation of treatment due to adverse drug reaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 13 Palpitation." data-id="CD004352-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 13 Palpitation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 14 Tachycardia." data-id="CD004352-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 14 Tachycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 15 Chest pain." data-id="CD004352-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 15 Chest pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 16 Dyspnoea." data-id="CD004352-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 16 Dyspnoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 17 Tremor." data-id="CD004352-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 17 Tremor.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 18 Hyperglycaemia." data-id="CD004352-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 18 Hyperglycaemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 19 Hypokalaemia." data-id="CD004352-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 19 Hypokalaemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 20 Nausea or vomiting." data-id="CD004352-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 20 Nausea or vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 21 Nasal stuffiness." data-id="CD004352-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 21 Nasal stuffiness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 22 Headaches." data-id="CD004352-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 22 Headaches.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 23 Neonatal death." data-id="CD004352-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 23 Neonatal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 24 Infant death." data-id="CD004352-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 24 Infant death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 25 Necrotising enterocolitis." data-id="CD004352-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 25 Necrotising enterocolitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 26 Sepsis or infection." data-id="CD004352-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 26 Sepsis or infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 27 Fetal hypoglycaemia." data-id="CD004352-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 27 Fetal hypoglycaemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 28 Fetal tachycardia." data-id="CD004352-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 28 Fetal tachycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 29 Infant long‐term neurological development (Bayley score: Psychomotor development)." data-id="CD004352-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 29 Infant long‐term neurological development (Bayley score: Psychomotor development). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All betamimetics versus placebo, Outcome 30 Infant long‐term neurological development (Bayley score: Mental development)." data-id="CD004352-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 All betamimetics versus placebo, Outcome 30 Infant long‐term neurological development (Bayley score: Mental development). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 1 Birth within 48 hours." data-id="CD004352-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 1 Birth within 48 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 2 Perinatal death." data-id="CD004352-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 2 Perinatal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 3 Respiratory distress syndrome." data-id="CD004352-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 3 Respiratory distress syndrome.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 4 Birth within 7 days." data-id="CD004352-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 4 Birth within 7 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 5 Birth less than 28 weeks' gestation." data-id="CD004352-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 5 Birth less than 28 weeks' gestation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 6 Cessation of treatment due to adverse drug reactions." data-id="CD004352-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 6 Cessation of treatment due to adverse drug reactions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 7 Any maternal adverse effects." data-id="CD004352-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 7 Any maternal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 8 Chest pain." data-id="CD004352-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 8 Chest pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 9 Shortness of breath or dyspnea." data-id="CD004352-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 9 Shortness of breath or dyspnea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 10 Hyperglycaemia or abnormal glucose tolerance test." data-id="CD004352-fig-0044" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 10 Hyperglycaemia or abnormal glucose tolerance test. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 11 Palpitations." data-id="CD004352-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 11 Palpitations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 12 Tachycardia." data-id="CD004352-fig-0046" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 12 Tachycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 13 Arrhythmia." data-id="CD004352-fig-0047" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 13 Arrhythmia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 14 Hypotension." data-id="CD004352-fig-0048" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 14 Hypotension.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 15 Nausea or vomiting." data-id="CD004352-fig-0049" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 15 Nausea or vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 16 Headache." data-id="CD004352-fig-0050" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 16 Headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 17 Anxiety." data-id="CD004352-fig-0051" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 17 Anxiety.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 18 Necrotising enterocolitis." data-id="CD004352-fig-0052" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 18 Necrotising enterocolitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-002-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-002-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Terbutaline versus ritodrine, Outcome 19 Neonatal death." data-id="CD004352-fig-0053" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2 Terbutaline versus ritodrine, Outcome 19 Neonatal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-002-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fenoterol versus ritodrine, Outcome 1 Perinatal death." data-id="CD004352-fig-0054" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Fenoterol versus ritodrine, Outcome 1 Perinatal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fenoterol versus ritodrine, Outcome 2 Respiratory distress syndrome." data-id="CD004352-fig-0055" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Fenoterol versus ritodrine, Outcome 2 Respiratory distress syndrome.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fenoterol versus ritodrine, Outcome 3 Tachycardia." data-id="CD004352-fig-0056" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Fenoterol versus ritodrine, Outcome 3 Tachycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fenoterol versus ritodrine, Outcome 4 Hypoglycaemia." data-id="CD004352-fig-0057" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Fenoterol versus ritodrine, Outcome 4 Hypoglycaemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fenoterol versus ritodrine, Outcome 5 Fetal bradycardia." data-id="CD004352-fig-0058" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Fenoterol versus ritodrine, Outcome 5 Fetal bradycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fenoterol versus ritodrine, Outcome 6 Neonatal death." data-id="CD004352-fig-0059" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Fenoterol versus ritodrine, Outcome 6 Neonatal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 1 Birth within 48 hours." data-id="CD004352-fig-0060" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 1 Birth within 48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 2 Respiratory distress syndrome." data-id="CD004352-fig-0061" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 2 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 3 Periventricular haemorrhage grade 3‐4." data-id="CD004352-fig-0062" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 3 Periventricular haemorrhage grade 3‐4. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 4 Birth less than 34 weeks." data-id="CD004352-fig-0063" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 4 Birth less than 34 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 5 Birth less than 37 weeks." data-id="CD004352-fig-0064" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 5 Birth less than 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 6 Any maternal adverse effects." data-id="CD004352-fig-0065" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 6 Any maternal adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 7 Palpitations." data-id="CD004352-fig-0066" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 7 Palpitations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 8 Tachycardia." data-id="CD004352-fig-0067" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 8 Tachycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 9 Nausea or vomiting." data-id="CD004352-fig-0068" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 9 Nausea or vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 10 Headache." data-id="CD004352-fig-0069" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 10 Headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 11 Sepsis." data-id="CD004352-fig-0070" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 11 Sepsis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 12 Neonatal death." data-id="CD004352-fig-0071" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 Ritodrine loading dose versus incremental dose, Outcome 12 Neonatal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hexoprenaline versus ritodrine, Outcome 1 Cessation of treatment due to adverse drug reactions." data-id="CD004352-fig-0072" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Hexoprenaline versus ritodrine, Outcome 1 Cessation of treatment due to adverse drug reactions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hexoprenaline versus ritodrine, Outcome 2 Any maternal adverse effects." data-id="CD004352-fig-0073" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Hexoprenaline versus ritodrine, Outcome 2 Any maternal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hexoprenaline versus ritodrine, Outcome 3 Palpitations." data-id="CD004352-fig-0074" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Hexoprenaline versus ritodrine, Outcome 3 Palpitations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hexoprenaline versus ritodrine, Outcome 4 Hypotension." data-id="CD004352-fig-0075" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Hexoprenaline versus ritodrine, Outcome 4 Hypotension.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hexoprenaline versus ritodrine, Outcome 5 Nausea or vomiting." data-id="CD004352-fig-0076" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Hexoprenaline versus ritodrine, Outcome 5 Nausea or vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hexoprenaline versus ritodrine, Outcome 6 Increase in fetal heart rate." data-id="CD004352-fig-0077" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Hexoprenaline versus ritodrine, Outcome 6 Increase in fetal heart rate.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Hexoprenaline versus salbutamol, Outcome 1 Respiratory distress syndrome." data-id="CD004352-fig-0078" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Hexoprenaline versus salbutamol, Outcome 1 Respiratory distress syndrome.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Hexoprenaline versus salbutamol, Outcome 2 Cessation of treatment due to adverse drug reactions." data-id="CD004352-fig-0079" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Hexoprenaline versus salbutamol, Outcome 2 Cessation of treatment due to adverse drug reactions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Hexoprenaline versus salbutamol, Outcome 3 Any maternal adverse effects." data-id="CD004352-fig-0080" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Hexoprenaline versus salbutamol, Outcome 3 Any maternal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Hexoprenaline versus salbutamol, Outcome 4 Tachycardia." data-id="CD004352-fig-0081" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Hexoprenaline versus salbutamol, Outcome 4 Tachycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Hexoprenaline versus salbutamol, Outcome 5 Nausea or vomiting." data-id="CD004352-fig-0082" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Hexoprenaline versus salbutamol, Outcome 5 Nausea or vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Hexoprenaline versus salbutamol, Outcome 6 Headache." data-id="CD004352-fig-0083" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Hexoprenaline versus salbutamol, Outcome 6 Headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Hexoprenaline versus salbutamol, Outcome 7 Tremor." data-id="CD004352-fig-0084" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Hexoprenaline versus salbutamol, Outcome 7 Tremor.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 1 BIrth within 48 hours." data-id="CD004352-fig-0085" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 1 BIrth within 48 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 2 Side effects (overall)." data-id="CD004352-fig-0086" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 2 Side effects (overall).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 3 Tachycardia." data-id="CD004352-fig-0087" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 3 Tachycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 4 Dyspnea." data-id="CD004352-fig-0088" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 4 Dyspnea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 5 Nausea." data-id="CD004352-fig-0089" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 5 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 6 Anxiety." data-id="CD004352-fig-0090" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 6 Anxiety.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 7 Chills." data-id="CD004352-fig-0091" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 7 Chills.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 8 Oedema." data-id="CD004352-fig-0092" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 8 Oedema.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-007-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-007-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Terbutaline versus salbutamol, Outcome 9 Duration of hospital admission (days)." data-id="CD004352-fig-0093" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 Terbutaline versus salbutamol, Outcome 9 Duration of hospital admission (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-007-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Slow release versus normal release salbutamol, Outcome 1 Preterm birth (before 37 weeks)." data-id="CD004352-fig-0094" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Slow release versus normal release salbutamol, Outcome 1 Preterm birth (before 37 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Slow release versus normal release salbutamol, Outcome 2 Caesarean section." data-id="CD004352-fig-0095" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Slow release versus normal release salbutamol, Outcome 2 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Slow release versus normal release salbutamol, Outcome 3 Side effects leading to discontinuation of treatment." data-id="CD004352-fig-0096" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Slow release versus normal release salbutamol, Outcome 3 Side effects leading to discontinuation of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Slow release versus normal release salbutamol, Outcome 4 Nausea." data-id="CD004352-fig-0097" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Slow release versus normal release salbutamol, Outcome 4 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004352-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/urn:x-wiley:14651858:media:CD004352:CD004352-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_t/tCD004352-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Slow release versus normal release salbutamol, Outcome 5 Apgar score less than 7 at 5 minutes." data-id="CD004352-fig-0098" src="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Slow release versus normal release salbutamol, Outcome 5 Apgar score less than 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/media/CDSR/CD004352/image_n/nCD004352-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD004352-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">All betamimetics versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Birth within 48 hours of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.53, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Perinatal death (7 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.46, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cerebral palsy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.02, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Birth within 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>911</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.65, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Birth less than 37 weeks' gestation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.88, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pulmonary oedema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>852</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.03 [0.12, 74.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Cardiac arrhythmias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.54 [0.74, 16.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Myocardial ischemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.53 [0.72, 216.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.12, 20.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Cessation of treatment due to adverse drug reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1081</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.38 [5.21, 24.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Palpitation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.91 [6.46, 15.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Tachycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Chest pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>814</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.29 [3.81, 33.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Dyspnoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>814</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.86 [2.21, 6.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.74 [6.20, 18.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Hyperglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [2.05, 4.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Hypokalaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.07 [4.00, 9.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [1.29, 2.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Nasal stuffiness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [1.64, 5.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Headaches <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>936</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.07 [2.60, 6.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.27, 3.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Infant death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>750</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.05, 5.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.06, 2.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Sepsis or infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Fetal hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Fetal tachycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.4 [1.12, 5.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Infant long‐term neurological development (Bayley score: Psychomotor development) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐2.74, 5.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Infant long‐term neurological development (Bayley score: Mental development) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.20 [0.56, 9.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">All betamimetics versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004352-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Terbutaline versus ritodrine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Birth within 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [0.77, 5.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.99 [0.93, 4.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Birth within 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.57, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Birth less than 28 weeks' gestation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.08 [0.55, 7.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cessation of treatment due to adverse drug reactions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.24, 2.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Any maternal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Chest pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.55, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Shortness of breath or dyspnea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.41, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Hyperglycaemia or abnormal glucose tolerance test <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [1.05, 3.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Palpitations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.78, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Tachycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.43, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Arrhythmia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.04, 3.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.67, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.71, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.23, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.67, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.05, 5.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.42, 3.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Terbutaline versus ritodrine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004352-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Fenoterol versus ritodrine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.38, 10.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Tachycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.35, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.31, 5.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Fetal bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Fenoterol versus ritodrine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004352-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ritodrine loading dose versus incremental dose</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Birth within 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.60, 1.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.35, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Periventricular haemorrhage grade 3‐4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Birth less than 34 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.70, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Birth less than 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.60, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Any maternal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.43, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Palpitations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.23, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Tachycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.33, 2.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.38, 3.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.06, 15.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.23, 2.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 2.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ritodrine loading dose versus incremental dose</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004352-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Hexoprenaline versus ritodrine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Cessation of treatment due to adverse drug reactions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.08, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any maternal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.76, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Palpitations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.60, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.61, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.45, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Increase in fetal heart rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.56, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Hexoprenaline versus ritodrine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004352-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Hexoprenaline versus salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.54, 5.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cessation of treatment due to adverse drug reactions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Any maternal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.18, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Tachycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.34, 2.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Hexoprenaline versus salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004352-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Terbutaline versus salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 BIrth within 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.21, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Side effects (overall) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.42, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Tachycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.30, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Dyspnea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.15, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.39, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.28, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Chills <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.34, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Oedema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.17, 3.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Duration of hospital admission (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.19, ‐0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Terbutaline versus salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004352-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Slow release versus normal release salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Preterm birth (before 37 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.57 [0.29, 23.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.23, 7.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Side effects leading to discontinuation of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.06, 12.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Apgar score less than 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Slow release versus normal release salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004352.pub3/references#CD004352-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004352.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004352-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004352-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004352-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004352-note-0002">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004352\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004352\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004352\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004352\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004352\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004352.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004352.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004352.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004352.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004352.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716802576"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004352.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716802580"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004352.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da869dee31be3',t:'MTc0MDcxNjgwMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 